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FOREWORD 
The most profound statement I could find with which to introduce this 
dissertation came from the book I probably consulted as much as any other 
during my graduate studies: Experimental Surgery by Markowitz, Archibald, 
and Downie (1964). The paragraph below was found on page 7 at the end of 
their introductory remarks: 
Meliora sequi; This book aspires: we believe that the 
jack-of-all trades in our profession, the general surgeon, 
human or veterinary, will find it useful; so will that drawer 
of water, the urologist, and that hewer of wood, the orthope­
dist; so indeed will all workers in experimental biology—all, 
that is, except those incredible soothsayers of today, the 
Freudian psychoanalysts. These gentry may not read the stars, 
but they interpret dreams. True, they do not concentrate upon 
the entrails of chickens, but they do have more than a passing 
interest in the last inch of the human digestive tube. If you 
wish to know what to do until the psychiatrist arrives, you 
won't find it in this book. 
You won't find it in this dissertation, either! 
Paul J. Antoi 
March, 1984 
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INTRODUCTION 
The rate of removal of an indicator substance has been clinically 
established as an indication of normal or abnormal hepatic function 
(Bradley et al., 1945). Many liver-specific dye substances such as bromo-
sulfophthalein (BSP) or indocyanine green (ICG) have been developed with 
which to test the ability of the liver to remove an exogenous dye from the 
plasma. ICG dye has been shown to be an ideal test substance since its 
discovery in 1957 (Fox et al., 1957). ICG has two major advantages over 
other available dye compounds: 1) it undergoes no extrahepatic removal, 
and 2) it is completely recoverable in the bile. Because of these advan­
tages, ICG is ideally suited as an indicator in the determination of 
hepatic blood flow. 
In most methods available today, the determination of hepatic blood 
flow employs the Indirect Pick method and involves catheterization of a 
hepatic vein (Leevy, 1965). Aside from the considerable patient risk in­
volved in any catheterization procedure, the area sampled at a given time 
in the measurement of blood flow in the liver is small. Therefore, the 
important question becomes whether the mixing of the blood from the vari­
ous lobes of the liver is uniform enough to ensure a sufficient distribu­
tion of indicator in the determination of hepatic blood flow in the sam­
pled area. As will be seen later, this is not as important in humans as 
it is in canines due to the complexity of the canine hepatic venous sys­
tem. 
Since the total liver mass produces bile and ICG is completely re­
coverable in the bile, then the concentration of dye in the bile is 
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representative of the functional activity of the total liver mass, leaving 
no doubt it is indeed well-mixed. 
The purpose of the present study is to develop a system by which the 
hepatic transit of ICG from blood to bile can be measured accurately. In 
order to ensure precision in the measurements, a data handling system will 
be developed that will center on a computer-controlled network of devices 
to aid in the collection of data. 
This will result in curves of concentration of ICG vs. time for both 
blood and bile from an in vivo canine system. These curves will be com­
pared to similar computer-generated curves from a mathematical model de­
veloped to simulate hepatic clearance of ICG. The model is based on a 
five-compartment system consisting of blood pool, splanchnic bed, hepatic 
sinusoids, hepatic cells, and bile pool. When inserting estimated litera­
ture values for hepatic blood flow, bile flow, tissue dye transfer rate 
constants, and respective tissue volumes, the model will predict dye con­
centration vs. time for each compartment. The data from both the in vivo 
studies and the mathematical model will be collected from two experimental 
states: 1) a normal state, and 2) a shunted state where portal venous 
blood is completely diverted into the vena cava through an Eck fistula or 
portal-caval shunt. The shunted state should result in a reduction in 
total hepatic blood flow of 40 to 50 percent and thus decrease the dye re­
moval rate. From the analysis of the blood and bile curves generated by 
the in vivo data with support from the mathematical model, the dynamics of 
hepatic dye clearance may become better understood. 
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REVIEW OF LITERATURE 
Physiology of Indocyanine Green 
General characteristics 
Indocyanine green (ICG) is a water-soluble, tricarbocyanine dye which 
was developed by Fox and associates in 1957. They demonstrated ICG to 
have an absorption maximum of 800 nm, which is also the wavelength where 
oxyhemoglobin and deoxyhemoglobin have equal absorbance characteristics. 
This allows the dye to be detected in the blood independent of oxygen 
saturation (Fox and Wood, 1957; Fox et al., 1957). ICG is unstable in 
aqueous solution, but is stable in plasma up to seven hours. Barbier and 
DeWeerdt (1964) postulated that the presence of plasma proteins prevented 
a cyclizing reaction from occurring, which greatly reduced the absorbance 
characteristics of the molecule. 
When injected into the blood, ICG primarily binds to the alpha-1-
lipoproteins (Baker, 1966) and the albumins (Cherrick et al., 1960) in the 
plasma, and to the Y and Z proteins of the hepatic cytoplasm (Levi et al., 
1969). Paumgartner et al. (1970) demonstrated the uptake of ICG by the 
rat liver obeyed Michaelis-Menten kinetics, and doses of ICG less than 10 
mg/kg would fall within the linear region of the Michaelis-Menton curve. 
It was concluded that dye was not removed from the plasma by simple diffu­
sion, but rather by binding to a receptor or carrier substance similar to 
an enzyme-substrate mechanism. This supports the findings of Levi and 
coworkers (1969). 
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Studies which attempted to detect amounts of ICG in various other 
tissues such as kidney, muscle, and brain showed there is no uptake of 
dye by any tissue other than the liver (Rapaport et al., 1959; Cherrick 
et al., 1960; Leevy et al., 1963). 
Blood removal characteristics 
The clearance of ICG from the blood has been shown to be a single 
exponential decay in the rat, rabbit, dog, and man, and is dependent on 
dosage in all test animals (Wheeler et al., 1958; Hunton et al., 1960b, 
1961; Klaassen and Plaa, 1969). In addition, Klaassen and Plaa have sug­
gested the single exponential decay is due to the one-way uptake of dye; 
i.e., there is no backflow of dye from liver to blood. Table 1 is a 
summary of dye removal rates. 
Table 1. Measured rate of ICG removal in normal dogs 
Authors Dose (mg/kg) PDR (range)^  
Wheeler et al. (1958) 1.05 6.6 
Hunton et al. (1960b) 1.00 7.6 (5.5-9.8) 
Hunton et al. (1961) 1.00 5.8 (4.5-7.4) 
Klaassen and Plaa (1969) 1.00 10.0 
Vogin et al. (1960) 0.50 9.7 (4.9-16.7) 
A ln(Ci/C2)xl00 
Percentage Disappearance Rate (PDR) = — min"l where 
C]^  = ICG concentration at time 1 and C 2~ ICG concentration at time 2. 
In addition to calculation of PDR, the percent retention at 20 min­
utes post-injection is another means of measuring ICG uptake. Percent 
retention is calculated as a percentage of the zero-time concentration 
found by extrapolation. A value of retention greater than 3% is consid­
ered abnormal (Cobb and Saunders, 1970). 
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Hunton et al. (1961) and Klaassen and Plaa (1969) demonstrated the 
relationship between dosage of ICG and PDR to be a nonlinear, inverse 
relationship. A later study by Iga and Klaassen (1979) showed a linear 
relationship between the dosage of ICG and the area under the concentra­
tion vs. time curve. 
Hunton et al. (1961) also discussed the apparent competition for 
hepatic uptake of ICG by other substances such as BSP, bilirubin, and rose 
bengal. It would appear a similar transport mechanism exists which is 
shared by all of the various indicators and there is no preference of one 
substance over another for removal from the blood. 
The rate of ICG uptake can also be affected by the presence of 
cardiovascular pathology. Hood et al. (1968) reported a 41% decrease from 
normal in the plasma clearance of ICG in dogs three to four days following 
surgical ligation of the left coronary artery. It was hypothesized that 
the more severe cardiac impairment immediately following myocardial in­
farction may be the cause of sustaining injury to the liver. 
Cobb and Saunders (1970) reported percent retention values in humans 
ranging from 3.46 to 4.15% one month following mild to severe myocardial 
infarction, respectively. It was stated that the impairment appeared to 
continue for some time when, presumably, the circulation was normal, as 
indicated by presence of normal blood pressures and the lack of evidence 
of cardiac failure. 
Edwards et al. (1972) conducted a study of human patients presenting 
varying degrees of reduced ventilatory capacity associated with chronic 
bronchitis. Twenty-one of 27 patients (78%) who showed a normal liver 
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function by a more conventional galactose tolerance test also showed an 
abnormal mean percent ICG retention of 4.7% (normal <= 3%), indicative of 
liver dysfunction. It was proposed that the common factor between these 
two tests was either a reduced hepatic blood flow, or a production of 
hepatic congestion preceding clinical heart failure. In support of com­
ments made by Leevy et al. (1962), it was concluded that hypoxia per se 
should not affect ICG clearance. They did not rule out, however, that 
nutritional changes in these patients could play a role in the altered 
liver function. 
Mechanism of Bile Formation 
General characteristics 
The bile canaliculi are the primary site of bile formation. The 
lumen of the canaliculi is separated from the adjacent cytoplasm by the 
unit membrane of the hepatocytes with the available area for diffusion 
augmented by the presence of microvilli. Therefore, the canalicular net­
work may be regarded as a single chamber separated from the hepatocytes 
by a thin membrane of large surface area (Wheeler, 1965). The movement of 
substances into the bile is difficult to ascertain due to the difficulty 
in measurement of the electrochemical conditions on both sides of the 
hepatocyte membrane. The supposition that bile is formed by an active 
transport or secretion process is based on one or more of three indirect 
types of evidence; 
1) The concentration of a substance in the bile, e.g., bilirubin, 
is significantly higher than that of the plasma such that it 
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could not have entered the bile by passive diffusion alone. 
2) A saturation maximum, or transport maximum, can be demonstrated 
which is consistent with the "carrier" hypothesis for active 
transport. 
3) Bile transport can be inhibited by substances known to be either 
rapidly excreted in the bile or disruptive to transport processes 
in other tissues. 
The major determinant of bile flow is the hepatic secretion of 
osmotically active organic anions into the bile canaliculi with the forma­
tion of bile itself contingent on perfusion of the hepatocytes by the 
blood. Appropriate concentrations of cations are simultaneously deliv­
ered into the bile to maintain electrochemical neutrality. The non-
diffusable, osmotically active anions then initiate passive diffusion of 
water into the bile in order to maintain isotonicity (Roullier, 1964). 
Bile ICG excretion characteristics 
After ICG is removed from the blood, it is excreted into the bile. 
Cherrick et al. (1960) and Caesar et al, (1961) reported ICG in plasma and 
bile to have uniform chromatographic migration. Barbier and De Weerdt 
(1964) confirmed by infra-red spectrography there is no molecular change 
in the ICG that appears in the bile from the ICG injected in the plasma. 
Therefore, ICG does not undergo any conjugation as it transits the liver 
cell, unlike bilirubin and BSP. Hargreaves (1966) suggested ICG is ex­
creted by a slightly different mechanism than bilirubin or BSP and may not 
require the UDP-trans-glucuronylase system for excretion. 
8 
Wheeler et al. (1958) showed ICG to be 97.3% recoverable in bile four 
to five hours after a single injection. Hunton et al. (1960a) reported 
81.4% recovery after four hours and 95.3% recovery after eight hours with 
peak concentrations occurring at 1 to 1.5 hours following a single injec­
tion. Ketterer et al. (1960) reported an average recovery of 91% with 
several 100% recoveries after six to seven hours with peak concentrations 
occurring two to three hours after injection. 
Klaassen and Plaa (1969) indicated bile flow in dogs to remain un­
altered for up to two hours after injections of 1 or 4 mg/kg of ICG. How­
ever, Wheeler and Ramos (1960) emphasized there would be a progressive and 
often profound depression in the flow of bile unless steps were taken to 
replace the lost bile salts during any study where bile was removed and 
not replaced. 
Hunton et al. (1960a,b) found when ICG was constantly infused, negli­
gible amounts of dye could be measured in the hepatic lymph. However, 
immediately following biliary obstruction, the dye concentration in the 
hepatic lymph elevated directly concomitant to the level of dye in the 
plasma and never exceeded the plasma dye content. They suggested lymphat­
ic ICG is dependent on plasma concentration, not on bile concentration, 
and furthermore, that ICG does not diffuse across the biliary mucosa 
during bile obstruction and therefore, the membrane remains relatively 
intact. 
Wheeler et al. (1958) also reported when a dose of ICG is introduced 
directly into the small intestine, only 1.9% of the initial dose is meas-
ureable in the bile after four hours. They concluded intestinal reabsorp-
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tion and recirculation of ICG would be insignificant compared with the dye 
decay in the plasma. 
Determination of Hepatic Blood Flow 
Most methods available today for measurement of hepatic blood flow 
are based on the indirect Pick principle and are complicated by the need 
for catheterization of a hepatic vein, as first described by Warren and 
Brannon (1944). In humans, a catheter is introduced into the median 
basilic vein of the forearm and, with the assistance of a fluoroscope, 
passed through the superior vena cava and right atrium into the inferior 
vena cava. Final placement of the catheter is usually into the right 
hepatic vein, which is less difficult than placement in the left hepatic 
vein. In the canine, the catheter passes directly into the inferior vena 
cava from the superior vena cava, bypassing the right atrium altogether 
(Miller et al., 1968) with final placement usually in the left hepatic 
vein. 
Other more invasive methods exist such as that described by Hand 
et al. (1981) which employs the surgical application of continuous wave 
Doppler flow cuffs to both the hepatic artery and the portal vein. How­
ever, the discussion that follows will be directed toward methods which 
are relatively noninvasive. In a discussion by Leevy and Gliedman (1958), 
contraindications to hepatic vein catheterization in humans were dis­
cussed. These included severe debility, lack of cooperation, septicemia, 
and history of pulmonary embolization from a fibrillating right atrium. 
Furthermore, since the catheter may enter the right ventricle, the pro­
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cedure was not recommended if arrthythmia, recent myocardial infarction, 
or active rheumatic myocarditis is presented. Finally, they stated com­
plications normally seen in cardiac catheterization such as arrhythmia, 
conduction defects, syncope, air emboli, catheter knotting, and bacterial 
endocarditis have not occurred with hepatic vein catheterization in more 
than 1000 cases reported in the literature. 
Indicator substances 
Many substances have been developed with which to measure hepatic 
blood flow (HBF). Regardless of whether an infusion or Injection method 
is employed, they allow HBF measurement by indicator-dilution and the 
application of the indirect Fick principle. These substances Include 
Chromium-51 (Shoemaker et al,, 1961; Thome et al., 1979), Xenon-133 
(Strandell, 1978), Iodine-131-Albumin (Shoemaker et al., 1961; Cohn 
et al., 1972), and para-amlnohippuric acid (Katz and Bergman, 1969). The 
most popular substances with which to measure HBF have been BSP and ICG, 
which will be discussed below. 
Infusion methods 
The method of infusion of an indicator substance into the liver is 
perhaps the most popular method for determining hepatic blood flow (HBF) 
since it was first described by Bradley et al. (1945) for BSP. When the 
Indicator substance is Infused, the estimated hepatic blood flow (EHBF) is 
calculated from the following formula: 
BHBF . ^  % 1 - heLtocrlt 
where R = removal rate in mg/min and P - H = peripheral - hepatic vein 
concentration difference in mg/ml. Since the indicator infusion rate (I) 
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will not always achieve equilibrium with the hepatic system, a correction 
of the infusion rate must be performed to estimate R accurately. If I is 
greater than R, then the excess must be extracted; i.e., R = I - AP x V 
where AP is the peripheral increment and V is the plasma volume. If I is 
less than R, then R = I + AP x V (Bradley et al., 1945; Waldstein and 
Arcilia, 1958). Substituting into (1), the working formula becomes 
EHBF • I ^  f h" " " 1 - hltocrlt ® 
Because indicator substances such as ICG and BSP do not enter the red 
blood cells, the extra term involving the hematocrit is necessary to 
account for the cell to plasma ratio to give blood flow. Otherwise, the 
calculation would result in the hepatic plasma flow. 
Numerous sites for infusion of dye substances have been used by 
various authors. ICG has been infused at a constant rate into the 
pulmonary artery (Ketterer et al., 1960), antecubital vein (Reemtsma 
et al., 1960), femoral artery (Caesar et al., 1961), or axillary vein 
(Stein et al., 1963). Samples of dye-containing blood may be arterial or 
venous, or the use of dichromatic ear densitometry (Leevy et al., 1967) 
may be employed. Table 2 contains a listing of normal hepatic blood flows 
as determined by ICG infusion. 
Winkler et al. (1965) performed a study in humans to determine HBF by 
placing two catheters primarily in the right lobe of the liver, one 
cranially and the other caudally. Five test substances including ICG were 
infused simultaneously with samples being taken from both hepatic venous 
catheters. This method was employed in an attempt to set duplicate de­
terminations of hepatic flow from the same liver. They stated the funda-
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Table 2. Normal hepatic blood flows 
Subjects Clearance^  EHBF^  Authors 
ICG infusion 
Dogs 3.3 36.9 Ketterer et al. (1960) 
Dogs 38.0 Banaszak et al. (1960) 
Humans 25.7 Reemtsma et al. (1960) 
ICG injection 
Dogs 3.2 37.6 Ketterer et al. (1960) 
Dogs 40.0 47.0 Banaszak et al. (1960) 
Dogs 8.4 60.0 Vogin et al. (1960) 
Humans 24.1 Reemtsma et al. (1960) 
m^l/inin*kg 
mental problem is how local changes in liver perfusion are related to 
change in hepatic extraction and vice versa. If local differences in ex­
traction do occur, it cannot be ascertained if the area is one of high 
perfusion or low extraction. Therefore, the confidence level of whether 
a hepatic venous sample is well mixed is not great. 
Caesar et al. (1961) stated that because ICG is removed only by the 
liver, it allows for the specific measurement of hepatic, not splanchnic, 
blood flow. Random changes in plasma levels caused by dye absorption by 
the gut are eliminated due to the absence of enterohepatic circulation, 
which is important in patients with extrahepatic shunts of splanchnic 
blood. 
Leevy et al. (1962) concluded ICG permits estimation of HBF in many 
patients with hepatic pathology in whom it is impossible to use BSP. They 
also stated hepatic hypoxia induced by either glucogen administration or 
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breathing ten percent oxygen does not influence hepatic extraction or 
hepatic blood flow when ICG is used. They found the best results for 
estimating HBF using the clearance method after a single injection of 
ICG, as compared to clearance of radioactive colloidal gold. 
Injection methods 
The method for calculating HBF using a single injection was first 
described by Dobson and Jones (1952) using radioactive colloidal chromic 
phosphate. It involves measuring plasma levels of an indicator substance 
serially for twenty minutes after injection while also measuring hepatic 
venous levels through a hepatic vein catheter. From the plasma concentra­
tions, the clearance (CI) rate may be calculated, and from the hepatic 
venous concentrations, the extraction ratio (ER) may also be calculated. 
The EHBF can then be computed from the following formulae: 
(3) 
Co Ti/2 
EE . (4) 
EHBF - II (5) 
where M = mass of dye injected, a = arterial concentration, CQ = dye con­
centration at zero time, HV = hepatic venous concentration, and T^ yg ~ 
half-time where concentration is one-half of C^ . The term M/CQ is the 
blood volume and 0.693 is equivalent to log (Cg/C^ yg)' Table 2 contains 
a listing of normal hepatic blood flows as determined by ICG injection. 
If the extraction ratio is not known, then the value for EHBF can be 
no more than the value of clearance found in (3). However, EHBF will be 
less than CI when ER is less than 1.0 (Waldstein and Arcilla, 1958). No 
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suitably ideal substance has been found to have an ER of 1.0 up to the 
present time. See Table 2 for normal hepatic flows determined by ICG 
injection. 
Reemtsma et al. (1960) reported a close correlation between hepatic 
blood flows measured by both the infusion and single injection methods 
within human individuals from control and cirrhosis groups. They proposed 
the use of a mean extraction ratio of 0.88 in normal human subjects which 
obviates the need for hepatic vein catheterization. 
Banaszak et al. (1960) used a slightly different method to calculate 
HBF in dogs by single injection of ICG. They defined hepatic dye clear­
ance by means of the use of a geometric average for plasma dye content, 
i.e., 
C - C 
V X  ^ (6) 
/C^  X Cg X (tg - tp 
rather than the logarithmic average as proposed by Dobson and Jones 
(1952). The results obtained were not significantly different from 
Ketterer et al. (1960), who used a logarithmic average. 
Noncatheterization methods 
Waldstein and Arcilla (1958) proposed a noncatheterization method 
employing galactose as a test substance. Following an intravenous dose of 
200 mg%, it was observed the characteristic plasma decay curve would pro­
duce a rectilinear phase followed by a curvilinear phase. Although 
galactose is primarily removed from the blood by the liver, the kidney 
also excretes enough galactose that the concentration in the urine must be 
taken into account to avoid errors. They suggested that at the point of 
transition between phases, the hepatic vein concentration would become 
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zero and the extraction ratio would then become 1.0. Thus, hepatic blood 
flow would be calculated as the ratio of the plasma removal rate during 
the rectilinear phase to the concentration at the phase transition point. 
It was concluded in this case there would be no need for hepatic vein 
catheterization since the extraction ratio could be determined from the 
peripheral decay curve alone. 
McLean et al. (1979) investigated a method by which hepatic blood 
flow could be determined by measuring two substances with very different 
decay characteristics in the same individual. Compounds with a high 
intrinsic clearance such as ICG have a high extraction ratio and clearance 
is dependent on hepatic blood flow, whereas compounds with a low intrinsic 
clearance such as antipyrine (AP) have a low extraction ratio and clear­
ance is limited by the ability of the liver to clear the compound inde­
pendent of blood flow. They proposed a noninvasive kinetic method com­
bining average values for intrinsic clearance of ICG and AP in normal 
populations with values of clearance obtained in a test subject to esti­
mate hepatic blood flow. The information obtained would also allow the 
prediction of the degree of shunting and the fraction of functional liver 
mass. This technique is limited, however, to what is termed the intact 
hepatocyte hypothesis in which chronic liver disease is associated with a 
reduction in cell mass with the individual cells experiencing normal 
function and perfusion. It was concluded any deviation from this hypothe­
sis would introduce errors in the estimation of hepatic blood flow. 
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Portal-Caval Shunting and Hepatic Blood Flow 
Anatomical considerations 
In a review article by Greenway and Stark (1971), it was stated that 
normal HBF as measured by BSP clearance was 43 inl/min*kg in conscious dogs 
and 39 ml/min*kg in dogs anesthetized with sodium pentobarbital. However, 
when measured using electromagnetic flowmeters, normal HBF was 31 ml/min* 
kg in conscious dogs and 36 ml/min*kg in anesthetized dogs. The contribu­
tion of the hepatic artery to total HBF was measured at 28% in conscious 
dogs and 29% in anesthetized dogs. Total HBF was 25% of the cardiac out­
put. This was followed by a discussion of the distribution of hepatic 
arterial blood and of whether this blood perfuses the same sinusoidal beds 
as the portal blood. It was concluded that there are both common and 
separate channels for arterial and portal blood with the majority of the 
sinusoids being perfused by both. However, a small part of the hepatic 
vascular bed is perfused only by portal blood at one instant while another 
small part, including the vessels around the biliary tracts and the con­
nective tissue, are perfused only with arterial blood. Furthermore, it 
was stated that in the normal liver, channels other than the sinusoids do 
not exist between the hepatic artery and hepatic vein or between the 
portal vein and the hepatic vein. 
These observations confirmed a more in-depth study by McCuskey (1967), 
who observed living liver tissue of frogs, rats, mice, and rabbits at 
various monochromatic light wavelengths through a special microscope/TV 
camera combination. 
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Effects of portal-caval shunts on HBF 
The need for portal-caval shunting in a clinical situation has been 
outlined previously (Antol, 1980). The discussion in the literature on 
the effects of portal-caval shunting on HBF and hepatic function is mostly 
limited to the conditions where patients already have abnormal hepatic 
dysfunction previous to shunt surgery. As a result, it is a rarity to 
find an instance in the literature of portal-caval shunting in normal 
subjects. 
In a study by Reynolds (1970), it was stated that a substantial de­
crease in HBF of 40-50% will occur after shunt surgery, with a greater 
decrease following a side-to-side (SS) shunt as opposed to an end-to-side 
(ES) shunt. They also discussed the findings of previous authors on the 
response of the hepatic artery after removal of portal blood flow during 
portal occlusion, and indicated a substantial rise in hepatic arterial 
flow (HAF) as measured by electromagnetic flowmeters. Normal humans 
undergoing cholecystectomy were found to have a 62% increase in HAF when 
the portal vein was clamped, while humans undergoing portal-caval shunt 
demonstrate a 20% increase in HAF. Other authors cited in this paper 
found a mean increase in HAF of 48% in eleven patients after an ES 
anastomosis, compared to a mean increase of 100% in eight patients follow­
ing an SS anastomosis. 
Burchell et al. (1976) reported a significant increase of 60% in HAF 
measured in 47 patients who received either an ES anastomosis or an SS 
anastomosis. Within those patients, there was also a correlation between 
patients who had a smaller increment in HAF and the presence of encepha-
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lopathy. Likewise, there was a correlation between patients experiencing 
small increments in HAF and survival while hospitalized. It was suggested 
from these observations that the increase in HAF following portal-caval 
shunting was due to the lowering of the sinusoidal pressure, and that 
failure to do so would result in the further development of complications. 
Johnson and Lambert (1967) studied changes in cardiac output in 
normal dogs following an ES anastomosis and observed a 35% increase over 
control dogs. It was stated that this effect was in accordance with 
Starling's law in that the shunted blood would increase the pre-loading of 
the right ventricle, thus increasing the force of contraction and the 
volume output from the left ventricle. 
In a later article, Reynolds (1974) concluded that porto-systemic 
shunting would never become an ideal surgical procedure due to the by­
passing of the detoxification action of the hepatic system and the re­
moval of the nutritive portal inflow. 
Mathematical Models of the Hepatic System 
With the advance of larger, faster digital computers, an increasing 
number of studies are being made in which problems of hepatic function, 
blood flow and clearance capabilities are solved mathematically. 
Richards et al. (1959) developed a mathematical model that predicted 
the content of BSP in the liver and bile given information obtained from a 
peripheral decay curve for BSP. The model was based on the solutions of a 
system of three first-order differential equations relating the change in 
mass of dye with respect to time for blood, liver, and bile. There were 
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two assumptions underlying this model: 1) all rates of transfer of BSP 
are proportional to the amounts of BSP from which the transfer occurs, and 
2) the amount of BSP transferred to extrahepatic or extravascular tissue 
is negligible. After a standard intravenous dose of BSP at 5 mg/kg, the 
resultant decay curve was analyzed graphically to determine the four 
constants needed by the constraint equations. The solutions yielded 
values for the mass transfer coefficients between the three compartments, 
and a proportionality factor relating the concentration in the plasma to 
the total amount of dye in the circulation. It was the authors' conten­
tion that this model would present more information than the standard 
forty-five minute retention of BSP alone. However, whether the second 
assumption, i.e., the negligible transfer of BSP to extrahepatic or 
extravascular tissue, is completely valid is subject to dispute, as indi­
cated by Leevy et al. (1962), and therefore, the quantitative accuracy of 
this method is questionable. 
Luxon et al. (1982) noted the model suggested by Richards et al. 
(1959) failed because it ignored concentration profiles in the sinusoid 
and mixing artifacts in the peripheral circulation. 
Giorgi and Segre (1973) conducted kinetic studies using BSP in normal 
rats and rats intoxicated with carbon tetrachloride (CCl^ ). The results 
of plasma decay and bile accumulation were fitted to a model consisting of 
four compartments and five transfer constants. The assumptions governing 
this model were more precise than Richards et al. (1959) in that they 
accounted for BSP losses in the extrahepatic space. The liver was modeled 
as two compartments because 1) the compartment representing BSP in the 
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blood is third-order with respect to BSP in the bile, and 2) the bile 
kinetics of BSP require four exponential terms. The transfer constants 
were determined by simultaneously fitting observed BSP levels in the blood 
and bile to the model. It was concluded the changes in transfer constants 
agreed with known effects of CCl^ , namely the intrahepatic transfer and 
uptake of BSP were reduced. 
Iga et al. (1980) conducted studies similar to Giorgi and Segre 
(1973), only with the use of ICG instead of BSP. In addition, a four-
compartment open model was developed to derive the transfer constants. 
Two schemes were proposed in which to classify the relationship between 
dye kinetics and compartmental arrangement. Scheme 1 included the sinu­
soid in the plasma compartment where transfer between compartments repre­
sents the translocation of the sinusoidal plasma membrane of the hepato-
cyte and the rate of transfer is much less than the plasma flow. Scheme 2 
placed the sinusoid in the liver compartment where transfer corresponds to 
the hepatic plasma flow and where there is a rapid equilibration between 
the sinusoid and hepatocytes, and the rate of transfer is approximately 
the hepatic plasma flow. Observations using ICG were made on normal rats 
and on CCI,-intoxicated rats in which the sinusoidal membrane was known to 
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be damaged. Since the product of the hepatic uptake constant and the 
blood volume is the hepatic blood flow, this product was compared to the 
measured hepatic blood flow and was found to be much smaller. It was 
concluded that Scheme 1 was the better representation, in which the 
permeability of the plasma sinusoidal membrane of the hepatocytes was the 
rate-determining step. 
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Numerous studies have been conducted in which the general pharmaco­
kinetics of hepatic clearance have been examined (Rowland et al., 1973; 
Perrier and Gibaldi, 1974; Wilkinson and Shand, 1975; Bass et al., 1976, 
1978; Bass and Bracken, 1977; Bracken and Bass, 1978; Bass and Robinson, 
1979). Given the complexity of the mathematics employed by these authors, 
a detailed discussion of these papers is beyond the scope of this project. 
However, in general there is agreement that clearance of any drug is the 
result of an exponential decay process. Furthermore, the blood-liver-bile 
system can be represented with a minimum of three compartments up to a 
maximum of twenty-five million compartments, which is the projected number 
of individual sinusoids (Bass et al., 1978). 
Recent work by Forker and Luxon (1978, 1982) has resulted in the 
development of a distributed model which takes into account intrahepatic 
concentration profiles, nonuniform blood flow distribution in the sinu­
soids, and delayed mixing in the peripheral circulation. The results 
indicated conventional "lumped" models underestimated the rate constants 
for hepatic uptake, but returned accurate estimates for steady-state 
plasma clearance and excretion rate constant (Luxon and Forker, 1982). 
Summary 
From the review of literature above, the characteristics of hepatic 
clearance of ICG from the blood and its hepatic excretion into the bile 
have been outlined. The available methods for the determination of 
hepatic blood flow using ICG have also been detailed. The effects of 
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portal-caval shunting on the hepatic system have been discussed. Finally, 
studies involving mathematical modeling of the hepatic system were pre­
sented. 
The intention of this collection of literature is to give support to 
the experimental design of the project to be discussed in the remainder of 
this dissertation. The understanding of the mechanism of hepatic dye re­
moval in the living system is crucial to the ability to design a mathe­
matical model for hepatic dye removal, and further, to design an experi­
mental system by which this model may be tested in the living system. 
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MATERIALS AND METHODS 
Experimental Design 
The design of this project has three objectives: 
1. Development of a mathematical model for hepatic blood clearance 
and bile accumulation of ICG. 
2. Development of a data-handling system with which to digitize and 
process data obtained from in vivo experiments. 
3. The implementation of those in vivo experiments in the canine in 
which plasma dye clearance and bile accumulation curves are 
obtained under conditions of normal hepatic blood flow and re­
duced hepatic blood flow as a result of a portal-caval shunt. 
Objective 1 involves production of data sets from the mathematical 
model representing dye concentration versus time for each of the five com­
partments modeled. Of particular interest will be the curves from the 
blood and bile compartments since these will be compared to those obtained 
from in vivo experiments. 
Objective 2 involves the design of the data-handling system to 1) 
assist in the initial set-up of each experimemt, 2) control the execution 
of each experiment, and 3) present the data from each experiment as re­
sults in a form such that further detailed processing is unnecessary. 
Objective 3 involves performing the experimental studies in mongrel 
dogs. Following injection of ICG, the parameters to be measured from each 
animal in addition to blood and bile dye concentration versus time will be 
cardiac output, hematocrit, and average bile volume per five minute inter-
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val, i.e., average bile flow. For each experiment, values for rate of dye 
disappearance, blood volume, and hepatic dye clearance will be obtained from 
the blood dye concentration data, while values of peak time, peak concen­
tration, amount of dye excreted vs. time, and percent dye recovery versus 
time will be obtained from the bile dye concentration data. 
Development of the Mathematical Model 
The mathematical model for hepatic dye clearance and bile excretion 
prepared in this research has been summarized previously (Antol, 1980; 
Antol and Engen, 1981). It is an extension of a model for hepatic dye 
clearance defined previously (Antol, 1980, 1981) and is similar in design 
to the model proposed by Iga et al. (1980). It employs a five-compartment 
system consisting of blood pool, splanchnic bed (gut, spleen, and portal 
venous system), hepatic sinusoids, hepatocytes, and bile pool (Figure la). 
The model is govenered by a system of five first-order differential equa­
tions (Figure lb) and was based on eight assumptions, as indicated by the 
literature. 
1. No site of dye removal from the blood exists other than the 
liver. 
2. The dye undergoes no generation or destruction. 
3. The bulk of the dye is not removed from the blood in a single 
pass through the liver. 
4. Portal blood flow is two-thirds of the total hepatic blood flow. 
5. Dye concentration in the hepatic lymph is negligible. 
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Figure 1. Compartmental diagram of mathematical model (A) and the system 
of five governing first-order differential equations (B) for 
normal hepatic clearance of ICG 
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6. Transport of dye from the sinusoids to the hepatocytes is pro­
portional to the sinusoid dye concentration only and reverse 
transport is negligible, 
7. Transport of dye from the hepatocytes to the bile pool is an 
active transport process and reverse transport is also negligi­
ble. 
8. All blood and tissue compartments are well-mixed and, therefore, 
the dye content of each compartment is homogeneous at any instant 
in time. 
In addition, the effects of reduced hepatic blood flow as a result of 
a portal-caval shunt have been modeled. This effect was programmed such 
that any amount of blood entering the liver from the splanchnic bed can be 
shunted back to systemic circulation. The eight assumptions listed above 
remain the same in the shunted case (Figure 2). 
The equations governing each blood compartment of the mathematical 
model are based on the "Fick principle" and are therefore constructed such 
that the following premise is obeyed: The compartment volume times the 
change in concentration with respect to time is equal to the flow through 
that compartment times the difference between the concentrations entering 
and exiting the compartment. This premise is shown as the following: 
' f - - C„) 
In the equation for the hepatic sinusoids, an extra term appears 
which is the removal or "clearance" term of dye solute from the blood to 
the hepatocytes, and is controlled by the sinusoid-hepatocyte transfer rate 
constant, K^ . From the sixth assumption, dye transport into the hepato-
27 
SHUNTED CASE 
BLOOD 
POOL 
S 
°L 
°HA 
CJQ 
fc îS's 
a 
1x1 
m 
dQp Cp 
SPLANCHNIC 
bed Vp Cp 
' fQc 
KH.  
°L " °HA * 
M (F = 1 
HEPATIC 
CELLS 
K LB 
BILE 
POOL 
ALAI 
ALELB  ^
DYE EQUATIONS-SHUNTED 
BLOOD POOL:  Vg^  = QLCS + (fQpCp - QHACB - QpCg 
SPLANCHNIC BED: Vp ^  = QpCg - fOpCp - dOpCp 
igpflTjc 
HFFFLTFÇ WIS: DT  ^" SFS • 
m PQQt-; 
dCi LB 
b dt ° "^LB^H " °LB^B 
B 
Figure 2. Compartmental diagram of mathematical model (A) and the system 
of five governing first-order differential equations (B) for 
shunted hepatic clearance of ICG 
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cytes is dependent only on the sinusoid dye concentration (Cg) and is 
independent of the hepatocyte dye concentration (C ). Therefore, the 
hepatocyte will theoretically hold any and all dye it receives without 
allowing any dye to be transported back into the sinusoid compartment. 
The hepatocyte equation is based on the assumption that the hepato-
cytes are a homogeneous, well-stirred tissue bed. Therefore, the change 
in hepatocyte dye concentration with respect to time is determined by the 
difference between the rate of dye transported into the cells from the 
sinusoids and the rate of dye transported from the cells into the bile. 
The bile pool equation is complex in that the change in bile concen­
tration with respect to time is determined by both a transport process 
into the bile pool and a flow-related process out of the bile pool. It is 
assumed that the transport of dye from the hepatocytes into the bile is an 
active process which has been documented in the literature (Roullier, 
1964). Therefore, the hepatocyte-bile transfer rate constant (K^ )^ is 
indicative of an active transport phenomenon, and transport of dye into 
the bile is likewise independent of bile dye concentration (C^ g) and also 
irreversible. 
Table 3 is a listing of parameters, literature values, and literature 
sources used for development of the initial conditions of the mathematical 
model. These values are averages as determined by the authors listed. 
Where possible, the given parameter has been determined in the same manner 
as that which will be used in this research; e.g., liver blood flow was 
determined by the single ICG injection method. 
Table 3. Initial conditions for mathematical model of hepatic dye removal in dogs as reported in 
the literature 
Parameter 
Model 
symbol Literature value Source Calculated value 
Body weight (BW) 
Hematocrit 
Dye dosage 
Liver blood flow 
Liver plasma flow QL 
Bile flow QLB 
Blood volume 
Plasma volume Vg 
Splanchnic plasma Vp 
volume 
Sinusoidal plasma Vg 
volume 
Hepatocyte volume Vjj 
Bile canalicular volume V^B 
Sinusoid-hepatocyte + Kjj 
transfer rate constant 
Hepatocyte-bile K 
transfer rate constant 
•LB 
18.8 kg (41.4 lbs) 
45 
1.0 mg/kg 
44.3 ml/min*kg 
24.4 ml/min*kg 
0.00735 ml/min*kg 
86.5 ml/kg 
52.1 ml/kg 
Equal to Vg 
9.7 ml/kg 
4.2% BW-VS-Vlb 
0.32 ml/kg 
3.3 ml/min*kg or 
40.0 ml/min*kg 
Schalm et al. (1975) 
Banaszak et al. (1960) 
Murray and Nebel (1959) 
Wheeler and Ramos (1960) 
Klaassen and Plaa (1969) 
Stekiel et al. (1960) 
Stekiel et al. (1960) 
Bradley (1963) 
Murray and Nebel (1959) 
Murray and Nebel (1959) 
Antol (1980) 
Wheeler and Ramos (1960) 
Ketterer et al. (1960) 
Banaszak et al. (I960) 
empirically determined 
0.833 L/min 
0.458 L/min 
0.000138 L/min 
1.626 L 
0.979 L 
0.182 L 
0.182 L 
0.602 L 
0.006 L 
0.062 L/min 
0.752 L/min 
+ equivalent to "clearance" 
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The value of Kg is equivalent to the clearance parameter as measured 
in the literature, although the range of reported clearances in Table 3 
was broad enough that all three are given. 
The value of will be estimated empirically such that the model 
will respond in the same manner as indicated by the literature; i.e., 
blood is completely cleared of dye in 30-40 minutes and accumulations in 
the bile are complete in four or more hours. 
The computer program of this mathematical model was written in 
FORTRAN and entered on a VAX/VMS 11/780 computer (Digital Equipment Corp., 
Maynard, MA). The solutions of the model system were obtained using a 
library subroutine which employs a rational extrapolation of Graggs' modi­
fied midpoint rule to solve systems of differential equations. As a re­
sult, the data sets returned by the program represent predicted dye con­
centration vs. time for all five modeled compartments. In Appendix A, a 
listing of the mathematical model program is given. 
Development of the Data-Handling System 
Equipment requirements 
The data-handling system was constructed around a PDP-8e computer 
(Digital Equipment Corp., Maynard, MA) which serves as the experimental 
controller. In addition, a PDP-11/23 computer system was used for data 
storage at the end of each experiment through a direct communication link 
with the PDP-8e system. A block diagram of the basic experimental equip­
ment arrangement is shown in Figure 3. 
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Figure 3. Block diagram of the basic experimental set-up for the data-
handling system 
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Blood and bile dye concentrations were determined using a Gilford 
103-IR densitometer (Gilford Instrument Laboratories, Oberlin, OH) which 
employed a continuous flow cell chamber. Output from the densitometer was 
fed into an A/D channel (±1.4 V maximum) of the PDP-8e. 
Since the flow cell would be exposed to heparinized blood continuous­
ly for periods up to one hour, a procedure was derived to prevent forma­
tion of thromboses within the cell. A solution was prepared consisting of 
a one-inch bead of Silastic adhesive. Type A (Dow Corning, Inc., Midland, 
MI) dissolved in 30 ml hexane, as described by Miller (1982). With the 
cell dismantled, the Silastic solution was flushed through the cell and 
the connecting fittings and allowed to dry overnight. A thin film of 
Silastic, known to greatly reduce thrombosis, would be deposited on all 
surfaces in contact with the blood. To further decrease the possibility 
of thrombogenesis, the glass windows of the flow cell were replaced with 
Plexiglas windows which were dipped in the siliconizing agent Prosil-2B 
(PGR Research Chemicals, Inc., Gainesville, FL). 
In parallel with the densitometer output was a Soltec 1241-3 strip 
chart recorder (Soltec Corp., Sun Valley, CA) which produced a back-up 
hard-copy of the dye dilution curve for determining cardiac output. In 
addition, the recorder contained a remote start feature which was linked 
to a relay in the computer to allow computer control of the chart. 
Arterial blood was pumped from the left side of the heart, through 
the flow cell, and returned to the right side of the heart using a Sarns 
Model 3500 roller pump (Sarns, Inc., Ann Arbor, MI). The overall flow 
rate of blood through this system was set at 40 ml/min. 
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The bile collected from the animal was passed through a drop de­
tector/cut-off valve assembly into a Fractomette 200 fraction collector 
(Buchler Instruments, Fort Lee, NJ). Upon command from the computer, a 
computer relay would cause fractions to change at five-minute intervals. 
The drop detector circuit (Figure 4) consisted of a single packaged, 
matched IR-LED/photodetector pair (Vactec VTL-11, Vactec Optoelectronics, 
St. Louis, MO, or equivalent) mounted on a Plexiglas support which was 
secured on a buret clamp. The voltage on the collector of the photo-
detector is normally biased high due to the low light transmission of the 
LED. As a drop of liquid enters the detector gap, a "lens" effect occurs 
and focuses the LED emission on the photodetector, resulting in a marked 
drop in the collector voltage. This in turn would initiate the timing 
cycle of a 555 timer (Signetics Corp., Sunnyvale, CA) configured in its 
monostable mode to produce a 36 ms pulse. The output pulse of the drop 
detector circuit was connected to a 0-5V sense line on the PDP-8e computer 
resulting in a high-low logic status being returned to the controlling 
program. 
The cut-off valve assembly was an accessory to the fraction collector 
that was modified to allow the computer to control its function; namely, 
to ensure a bile drop is not missed. The circuit designed for this device 
is shown in Figure 5. 
The timing of the computer program events and the interactions with 
the peripheral devices were governed by a 30 Hz external clock circuit 
(Figure 6). An overall clock rate of 30 Hz was chosen to allow for 
accurate digitization of the cardiac output dye-dilution waveform. The 
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Figure 4. Schematic diagram of drop detector circuit; see text for description of detector 
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37 
clock circuit relies on the 60 Hz line frequency as its reference and em­
ployed an MFC 6050 dual toggle flip-flop (available as EGG 767, GTE-
Sylvania, Williamsport, PA) as a divide-by-two frequency divider. 
Computer program design 
Six separate computer programs were written in BASIC to calibrate, 
control, record data, and compute results for each animal experiment. The 
six programs are shown in more detailed flow-charts in Appendix B and the 
actual program listings are given in Appendix C. A brief summary of the 
programs will be given in the following text. 
The program DATCAL allows the calibration of the densitometer for dye 
concentration in blood and bile samples and stores the standard curve data 
on the floppy disk. 
The program DATGET, the actual data-acquisition program in the 
series, provides prompts to configure the equipment in its starting modes, 
then gives a 60-second countdown to injection of the dye. When the dye 
has been injected, an internal program trigger waits until dye appears at 
the detector, then begins to sample the plasma dye-dilution curve at 30 Hz 
for 40 seconds. Subsequent plasma readings of the densitometer output are 
taken at one-minute intervals while bile drop totals are recorded at five-
minute intervals. 
Bile dye concentration for each fraction is determined by manually 
timing the passage of diluted samples through the pump and flow cell such 
that the sample is present in the flow cell when the computer records the 
densitometer output at the next one-minute mark. Those experiments in 
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which dye concentration in the hepatic venous blood was also measured were 
processed in this same manner. 
At the conclusion of the experiment, the data is stored in two 
separate files with cardiac output data separate from blood and bile data. 
The program CALOUT reads the calibration data files from the disk, 
performs a linear regression on the standard data for both blood and bile, 
and then computes and stores the slope and intercept information on the 
disk. The calibration data set is then transferred to the PDP-11 system. 
The program DATOUT reads the standard slope-intercept files and the 
data file for both blood and bile from a given experiment. The experi­
mental data are then converted to blood dye concentration, bile volume per 
five minute interval, and bile dye concentration. These results are then 
transferred to the PDP-11. 
Finally, the program CRDOUT analyzes the dye-dilution curve in a 
manner similar to previously described methods (Lin, 1979; Cole and 
Crawford, 1980). After computing the estimated downslope to eliminate the 
effect of recirculation, the area under the curve and resultant cardiac 
output is computed. The complete data set is then transferred to the 
PDP-11 and the program sequence ends. 
Experimental Procedure 
Sixteen mongrel dogs of both sexes (16.3-23.6 kg) were tested in this 
research project. Each animal was anesthetized initially with 22 mg/kg 
Surital (Thiamylal, Parke-Davis, Morris Plains, NJ) and following inser­
tion of an endotracheal tube, anesthesia was continued using Metophane 
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(Methoxyflurane, Pitman Moore, Inc., Washington Crossing, NJ)-Nitrous 
Oxide-Oxygen (0.1:2:1). Ventilation was assisted with a Bird respirator 
(Bird Corp., Palm Springs, CA) which was configured to assist rather than 
control ventilation. The use of a respirator was necessary to ensure 
proper anesthetic and metabolic gas exchange and to prevent any unnoticed 
apneic episodes due to sensitivity to Metophane, which may result In 
respiratory and/or cardiac failure in mid-experiment. 
The surgical procedure is detailed in Appendix D. All animals were 
subjected to ligation of the cystic duct and to cannulations of the common 
bile duct, femoral artery and femoral vein, and were evaluated for blood 
dye removal and bile excretion. Nine animals were normals, two were given 
portal-caval shunts, three had hepatic vein cannulations, and two had both 
hepatic vein cannulations and portal-caval shunts. 
Approximately 30-60 minutes after closure of the surgical sites, thus 
allowing sufficient time for coagulation of peripheral vessels in the 
surgical area, each animal was injected with 100 units/kg heparin solution 
(United States Biochemical Corp., Cleveland, OH). Additional heparin was 
injected over the duration of the experiment to maintain as close a non-
thrombogenic state as possible. 
In each experiment, a 25-mg vial of Cardio-Green (ICG, Hynson, 
Wescott, and Dunning, Baltimore, MD) was diluted with 1.0 ml distilled 
water to give a stock concentration of 25 mg/ml. From this dye stock, 
20 yl was diluted to 200 yl (1:10) for blood standards and 50 yl was 
diluted to 200 pi (1:4) for bile standards. Three 10 ml blood standards 
were prepared in duplicate by adding aliquots of 1:10 diluted dye to give 
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concentrations of 2.5, 5, and 10 mg/L. Two 25 ml bile standards were pre­
pared in duplicate in 25 ml volumetric flasks containing 2.0 ml canine 
blood plasma. Aliquot s of 1:4 diluted dye were added to each flask fol­
lowed by a sufficient quantity of saline to give concentrations of 5 and 
10 mg/L. 
When calibration was complete, the bile catheter was connected to the 
drop detector/cut-off valve assembly and the output from the detector was 
verified with both a storage oscilloscope and the data acquisition program 
to ensure the signal was being correctly propagated to the computer. 
The stock dye solution was prepared at 25 mg/ml in order to keep the 
injection volume small (mean =0.78 ml). This results in a very sharp dye 
pulse upon rapid injection which closely approximates the Dirac delta 
function. The dose of injected dye was 1 mg/kg. 
The first 60 minutes of a given experiment was noneventful with the 
computer in complete control. After that time, the pump was stopped and 
the densitometer and cannulas were flushed with heparinized saline. Both 
cannulas were then connected to Statham P23Dc (arterial) and PR23ID 
(venous) pressure tranducers (Statham Laboratories, Inc., Hato Rey, 
Puerto Rico) to allow monitoring of blood pressures in the latter stages 
of the experiment when the potential for acidotic shock becomes more 
critical. In the animals that did show signs of shock, especially those 
with hepatic vein cannulations, infusions of 8.4% sodium bicarbonate 
solution (Med-Tech, Elwood, KS) were usually sufficient to restore pres­
sure. In some animals, however, the bicarbonate infusion was not com­
pletely effective and, therefore, it was also necessary to administer 
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calcium gluconate solution (Abbott Laboratories, North Chicago, XL) to 
increase cardiac contractility. 
In those animals in which portal-caval shunts and hepatic vein 
cannulations were performed, a 2.5 ml/min intravenous drip of lactated 
ringers solution was infused to further stabilize the animal and to 
counter hypovolemia due to hemorrhage in the shunt and hepatic vein area. 
The amount of fluid infused never exceeded the amount of fluid collected 
from the abdominal cavity at the end of an experiment, which ranged from 
500-750 ml. 
After 110 minutes elapsed time, preparation was begun for bile sample 
analysis. In a similar manner to the preparation of the bile standards, 
2.0 ml canine blood plasma was added to 25-ml volumetric flasks. Follow­
ing addition of 200 yl from each bile fraction, saline was added to the 
mark, giving a 1:125 dilution. Samples were measured until the dye con­
tent had fallen to 10-15% of the peak concentration, at which time the 
experiment was declared completed. 
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RESULTS AND DISCUSSION 
Animal Experiments 
The sixteen animals were divided into two groups for statistical 
analysis. Group I consisted of nine normal and two portal-caval shunted 
animals. Group II consisted of the animals with an hepatic vein cannula-
tion, and contained three normal and two shunted animals. The procedure 
for hepatic vein cannulation was never performed without difficulty. Un­
fortunately, both the large variability of the data and the small sample 
size in Group II have contributed to inability to resolve any true sig­
nificance from this group. The manipulation of the liver lobes may have 
introduced enough variability into the data to cause the inaccuracies in 
the results of Group II. Therefore, the validity of the data in Group II 
is in question. This is certainly evident in the values for EHBF and 
EHBF/body weight, which are far below accepted normal levels of EHBF as 
determined by a single injection of ICG. As a result, the discussion of 
the animal results to follow will be centered on the Group I results. 
The individual results from each animal experiment for blood ICG re­
moval and bile ICG accumulation in both groups are listed in Appendix E. 
Two computer programs were written in BASIC for the analysis of the 
experimental data. The listings of the programs KTEST and BILTES are 
given in Appendix F. The program KTEST was designed to read in the blood 
concentration files, perform a linear regression of the data within a 
designated range, and calculate the slope, y- and x-intercepts, and the 
hepatic clearance of ICG in addition to the other measured blood parame­
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ters. The program BILTES was designed to read the bile concentration and 
bile volume files and calculate peak time, peak concentration, and mean 
bile flow in addition to other measured bile parameters. Table 4 is a 
listing of all measured and calculated parameters from the experimental 
data. The means and standard errors from the experimental data are given 
in Table 5. All indications of significance in the following text were 
obtained using the Student's t-test with p S 0.05 as the minimum level of 
significance (Steel and Torrie, 1980). The average values given in the 
following text will be shown as mean ± standard error of the mean. 
The measured values for body weight were 18.6±0.7 kg (n = 9) for the 
normal animals and 19.5±0.9 kg (n = 2) for the shunted animals, with an 
average group weight of 18.8 kg (n = 11). The hematocrit, which was 
measured during the calibration procedure, averaged 41±2% in the normals 
and 49±1% in the shunted animals. Overall, there was little variation in 
the size of the animals between normal and shunted dogs. 
The measured cardiac output in the normal animals was 0.156±0.014 L 
min~^  kg"\ which is in the normal range for dogs (Schalm et al., 1975; 
Swenson, 1977). However, the cardiac output dropped significantly 
(p < 0.01) by a factor of two in the shunted animals to 0.073±0.008 L 
min ^  kg This finding is contradictory to the findings of Johnson and 
Lambert (1967), who reported an increase of 35% in cardiac output in nor­
mal dogs given portal-caval shunts. This difference may be explained by 
the fact that the dogs studied by Johnson and Lambert had chronic shunts 
and cardiac output measurements were not performed until four weeks after 
the surgery. In the case presented here, the animals were tested for 
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Table 4. Derivations of parameters calculated from experimental data 
Parameter Symbol Method of calculation 
Cardiac output CO directly from CRDOUT program 
Blood concentration CB directly from DATOUT program 
Blood y-intercept IB intercept from In (Cg) vs. time 
Initial blood 
concentration 
B^O antilog of Ig 
Dye dosage D total dye injected determined 
by 1 mg/kg x body weight (kg) 
Blood volume VB^  D divided by CgQ 
Plasma decay rate KB slope of In (Cg) vs. time 
Clearance Cl* Kg X Vg 
Area under blood 
concentration curve 
AUCB SCgt from t = 0 to t = Tg^ g 
Time to zero blood 
concentration 
TSCO Ig divided by Kg 
Bile volume/5 mln 
interval 
VBL5 directly from DATOUT program 
Mean bile flow QLB^  VgLs divided by 5 
Bile concentration CLB directly from DATOUT program 
Peak time FT directly from C%^ g vs. time 
Peak concentration C^LB directly from C^ g vs. time 
Area under bile curve 
Total concentration AUCLB ECj^ gt from t = 0 to t = T g^O 
Total dye mass AUClbM SCLBVBLS from t = 0 to t = T^ ^^  
Ascending conc. AUCLBU ZCj^ gt from t = 0 to t = TgQ 
Ascending dye mass 
^^ L^BMU ^CLB B^LS from t = 0 to t = TBQ 
Ascending slope KLBU slope of In (C^ g) vs. time from 
t = 0 to t = Tgo 
Descending slope %BD slope of In (C^ g) vs. time from 
t = ICQ to t = Tj^ gQo 
Bile y-intercept L^B Intercept from In (Cj^ g) vs. 
time from t = 100 to t = TLQCO 
M^athematical model parameters. 
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Table 4. (Continued) 
Parameter Symbol Method of calculation 
Initial bile cone. ^LBO antilog of Ilb 
Time to zero bile 
concentration 
TLBCO ILB divided by 
Dye recovery %R X 100 from t = 0 
to t = Tp 
Final measured time TF time of last measured bile sam­
ple when experiment ended 
Mean blood 
concentration 
^B AUCg divided by Tgo 
Mean bile 
concentration 
^B AUClb divided by TLBCO 
Volume of bile 
canaliculi 
VLB  ^ D divided by CLBO 
Mean dye residence 
time 
cardiac output within three hours after the creation of the shunt. It is 
possible that the change in normal hepatic circulation might result in an 
onrush on the cardiopulmonary vasculature of a vasodilatory substance con­
tained in portal blood and may be acutely responsible for the decrease ob­
served in cardiac output. When the blood pressure transducers were con­
nected to the cannulas at 60 minutes post dye injection, both arterial and 
venous blood pressures were within the normal region of pressure. Heart 
rate was monitored throughout the experiment and usually remained between 
110-130 bpm. It is also possible that the heparinization of the animal 
1.5-2 hours prior to beginning the experiment caused enough fluid loss 
that the animal was in hypovolemic shock. This point is doubtful since if 
hypovolemia was indeed producing a state of shock in the animal, it is 
Table 5. Averages from animal studies and mathematical model for ICG removal in normal and 
shunted cases 
Blood 
^BO BV BV/BW % CI AUCG TBCO 
(mg L-1) (L) (L kg-1) (min"l) (L min"^ ) (mg min L"^  ) (min) 
Normal 14.2^  2.36 0.127 -0.0889 -0.206 1347 29 
n = 9 (1.1) (0.20) (0.010) (0.0068) (0.018) (209) (2.0) 
Model 11.9 2.77 0.147 -0.0925 -0.256 897 25 
Shunt 15.7 2.51 0.130 -0.0690* -0.171 2421** 40** 
n = 2 (2.8) (0.38) (0.026) (0.0055) (0.013) (180) (0) 
Model 11.9 2.77 0.147 -0.0544 -0.151 2759 45 
Bile 
QLB FT PC AUCLB AUCLBM AUCLBU ^^ L^BMU L^BU KLBD CLBO TLBCO 
(ml (mg (mg min (mg (mg min 
(mg min) (min-1) min~l) (min) L-1) L~lxlO^ ) min) L-1) (min-1) (mg L" "^ ) (min) 
Normal 0.162** 42 1203 1.53 1052 61189 52.6 0.1491 -0.0201 4610 485 
n = 9 (0.018) (4) (147) (0.32) (92) (13615) (12.0) (0.0163) (0.0029) (1371) (83) 
Model 0.160 45 1226 1.74 1412 50951 41.3 0.1144 -0.0229 6602 384 
Shunt 0.082* 39 1882 2.22 843 275573* 111.7* 0.1144 -0.0150 3127 558 
n = 2 (0.031) (6) (392) (0.59) (80) (75101) (14.5) (0.0704) (0.0029) (77) (105) 
Model 0.080 45 1678 4.94 2000 322090 130.4 0.0470 -0.0115 3597 709 
e^an ± SEM. 
^n = 8. 
p < 0.05. 
** -p < 0.01. 
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highly unlikely that the animal would have survived an experiment that 
could last another four hours. Mild neurogenic shock or shock induced by 
the handling of the gut during shunt surgery cannot be ruled out as possi­
bilities as well. Therefore, since blood pressures were not measured at 
the time of dye injection, the reason for the decreased cardiac output be­
comes difficult to ascertain. 
Blood results 
The plasma decay rate (Kg) in the normal animals is within accepted 
ranges reported by Hunton et al. (1960b, 1961) and Wheeler et al. (1958) 
for the rate of decay of ICG from the blood. The measured dye clearance 
in the normal dogs is between the values reported by Ketterer et al. 
(1960) and Banaszak et al. (1960). The value for K in the shunted animals 
is significantly lower (p < 0.05) than the normals, which also accounts 
for the significant increase in area under the curve (p < 0.01) and time 
to zero blood concentration (p < 0.01). Dye clearance in the shunted 
animals demonstrates a decreasing trend (p < 0.16). These changes are 
concomitant with the decrease in cardiac output discussed earlier. 
The blood volume to body weight ratio was higher at 13% than that 
which is normally accepted in the literature, namely 8-10%. Even though 
the animals had unknown clinical histories, they were not anemic since the 
mean hematocrits were normal. Stekiel et al. (1960) demonstrated that, 
within experimental error, blood volume determined by ICG was equal to 
blood volume determined by Evans' blue dye. Therefore, the blood volume 
to body weight ratio of 13% was most likely a normal condition in these 
animals. 
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Bile results 
The measured value for mean bile flow was 0.162+0.018 ml min ^  or 
0.0086 ml min ^  kg This value is in accordance with that reported by 
Klaassen and Plaa (1969) of 0.008 ml min  ^kg  ^for normal dogs. Klaassen 
and Plaa also reported a peak concentration time (?%) of 60 minutes, 
whereas Wheeler et al. (1958) reported a of 102 minutes. The litera­
ture values for peak concentration time are contrasted in this study by a 
P]i of 42 minutes in the normal animals, which is as much as 50% faster 
than the literature values. Bile flow is significantly reduced (p < 0.05) 
to 0.082±0.031 ml min ^ , a factor of two in animals with portal-caval 
shunts. Peak concentration and area under the total dye mass curve in the 
shunted animals show trends toward significance (p < 0.15 and p < 0.13, 
respectively). This is most certainly due to the small number of animals 
given shunt surgery. 
The area under the up-slope concentration curve and the area under 
the up-slope mass curve are also significantly larger (p < 0.05). All 
other measured values with respect to bile excretion of ICG are not sig­
nificantly different. 
In measuring ICG recovery, it was observed that 81.1% of the dye is 
removed in 162 minutes on average in the normal animals while 65.2% of the 
dye is recovered in a similar amount of time in the shunted animals. 
Hunton et al. (1960a) indicated an average 81% recovery of ICG from the 
bile after 240 minutes, while Wheeler et al. (1958) obtained an average 
80% recovery in approximately 210 minutes. It can be shown here that not 
only is the ICG being accumulated in the bile space at a faster rate in 
the normal animals, but also the presence of the portal-caval shunt causes 
this rate of accumulation to decrease. However, it is difficult to say if 
this effect is due strictly to the shunt, or again to the fact that the 
cardiac output was reduced and, therefore, perfusion of the liver was re­
duced proportionally. In any case, the hepatic blood flow (HBF) has been 
reduced. It is impossible to know quantitatively how much the HBF has 
been reduced without a second, independent method to measure blood flow 
(e.g., electromagnetic flowmeters). 
The more rapid recovery of dye in the present study could also be re­
lated to the type of anesthetic used. In most ICG clearance studies re­
viewed, the principle anesthetic was pentobarbital. Goodman and Oilman 
(1975) state that although barbiturates dp not affect hepatic function, 
they do affect the rate of synthesis of the Y and Z proteins responsible 
for uptake of hepatic anions such as ICG and the rate of biliary excretion 
of ICG. Additionally, cardiac output is reduced while total peripheral 
resistance increases. 
Following premedication with thiamylal, the principal anesthetic used 
in this study was methoxyflurane-nitrous oxide-oxygen (0.1:2.0:1.0). With 
regard to methoxyflurane, both Goodman and Oilman, and Soma (1971) 
state that hepatic impairment is slight and transitory, and there is 
tendency to reduce cardiac output as well. The effect of nitrous oxide on 
the liver is regarded as negligible, but data are lacking with respect to 
the combination of nitrous oxide and methoxyflurane. It should be noted 
that the discussions in the literature of methoxyflurane and its effects 
are respective to the use of methoxyflurane alone, which requires much 
higher concentrations than when used concomitant with nitrous oxide. 
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Mathematical Model 
It was observed that the initial conditions for the mathematical 
model calculated from the literature were decidedly different from the 
equivalent parameters measured in the animal experiments. Therefore, in 
order to test the model properly such that it might more closely agree 
with the animal results, the initial conditions of the model were assigned 
the values from the animal experiments performed herein. Table 6 is a 
listing of the differences between the calculated literature values and 
the actual values programmed into the model. The combined output of the 
five compartments of the mathematical model are shown in Figure 7 for the 
normal case and Figure 8 for the shunted case. 
The value for hepatocyte volume (Vg) was reduced by approximately two 
from 0.602 L to 0.304 L because the mathematical model would not respond 
similarly to the animal results with the larger value of Vy. The litera­
ture value for hepatocyte volume was determined at necropsy strictly on a 
wet weight per body weight basis and may not be an accurate measurement of 
hepatocyte cell volume. It is difficult to find an accurate prediction of 
hepatic cell volume, since most reported weights are also most likely wet 
weights determined at necropsy. Bloom and Fawcett (1975) state the aver­
age liver weight in the human to be 1.5 kg. If the average human body 
weight is assumed to be 70 kg, then the liver would be 2.1% of the body 
weight. Miller et al. (1968) state the mass of the liver to be 3.38% of 
the body weight in the dog. Therefore, it is certain that the estimate of 
4.2% of the body weight as an estimate of hepatic cell volume was over­
estimated. The volume of intercellular connective tissue in the liver 
Table 6. Comparison of calculated literature parameters and actual parameters from animal studies 
used in initial conditions of mathematical model for ICG removal 
Parameter Literature value 
Calculated 
literature value 
Actual value 
used in model 
Body weight (BW) 
Hematocrit 
Dye dosage 
Hepatic blood flow 
Hepatic plasma flow (Q^ ) 
Bile flow (Qlb) 
Blood volume 
Plasma volume (Vg) 
Splanchnic plasma volume (Vp) 
Sinusoidal plasma volume (Vg) 
Hepatocyte volume (Vjj) 
Bile canalicular volume (Vj^ g) 
Sinusoid-hepatocyte 
transfer rate constant (Kg) 
Hepatocyte-bile transfer rate 
constant (K^ g) 
45 
44.3 ml min ^kg ^ 
0.00735 ml min ^kg ^ 
9.2% BW 
equal to Vg 
9.7 ml kg-1 
4.2% BW-VS-VLB 
0.32 ml kg-1 
3.3 ml min ^ kg  ^or 
40.0 ml min"1kg-1 
45 
0.833 L min 
0.458 L min 
-1 
-1 
0.000138 L min 
1.73 L 
0.985 L 
0.182 L 
0.182 L 
0.602 L 
0.00602 L 
0.062 L min~^  
0.752 L min-1 
empirically 
determined 
-1 
18.8 kg 
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18.8 kg 
0.475 L min - 1  
-1  0.000162 L min 
[0.000081 L min-1] 
2.44 L 
1.39 L 
0.182 L 
0.182 L 
0.304 L 
0.007 L 
0.206 L min-1 
[0.171 L min-1] 
0.0142 L min-1 
[0.0520 L min-1] 
[ ] = values used in shunted case 
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Figure 7. Resultant output of mathematical model for hepatic removal of 
ICG for the normal case: A, predicted dye concentration vs. 
time from blood pool (B), splanchnic bed (P), hepatic sinusoids 
(S), and hepatocytes (H); B, predicted dye concentration vs. 
time from bile pool compartment (LB) 
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would account for the excess volume in the value of V after the volumes of 
the sinusoid and bile canaliculi have been deleted. In using the lower 
number for hepatocyte volume, the model behaved in a manner comparable to 
the animal data in terms of P^ , and T^ gco" 
The hepatocyte-bile canalicular transfer rate constant (K^ g) was em­
pirically determined in order to cause the model to respond as closely as 
possible to the animal data. In the normal case, animal data and model 
data were consistent when the value for was established to be 6.9% of 
the sinusoid-hepatocyte transfer rate constant (K^ ). 
The shunted case, however, exhibited a twofold decrease in bile flow, 
and showed no significant difference in peak concentration time. There­
fore, the hepatocyte-bile transfer rate constant (K^ g) would have to in­
crease four times in order to maintain a similar pattern of bile ICG ex­
cretion. 
Bile is formed by the active secretion of organic anions such as ICG 
and the rate of bile flow is directly proportional to the rate of anion 
secretion (Roullier, 1964). In the present study, it was found that in 
order for the model data for bile excretion to fit the animal data for 
bile excretion in the shunted case, there would have to be an inverse re­
lationship between bile flow and the rate of anion excretion. Since this 
is contradictory to the accepted mechanism for bile formation, it is 
necessary to conclude that the data from the shunted animals may be un­
reliable. The animals in this case may have been physiologically unstable 
as reflected by the 50% decrease in cardiac output. 
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In addition to the mean and standard error values from the animal 
studies. Table 5 also contains the equivalent results from the mathemati­
cal model as compared to the animal studies. It can be observed by in­
spection that even though the model results are not identical to the 
animal results, it does react similarly with respect to the inflections 
in the blood and bile response of the normal animal studies. Figures 9-
12 demonstrate graphically the relationships between the results of the 
animal studies and mathematical model. 
Table 7 is a comparison of specific blood and bile parameters. These 
parameters were computed in an attempt to observe differences between the 
normal and shunted animals in the analysis of the mathematical model re­
sults. Since it is known that a portal-caval shunt does alter the blood 
flow through the hepatic system, these ratios were chosen as a possible 
indication of how much change has occurred. Only the difference in mean 
blood concentration of ICG (Cg) between normal and shunted animals was 
determined to be significant. The ratio of mean bile concentration (C^ )^ 
to mean blood concentration (CL) is an index of the average concentrating 
capability of the liver and measured 83.9 in normal animals which de­
creased insignificantly to 64.5 in the shunted animals. The ratio of 
to CgQ is an indication of the maximum concentrating capability of the 
liver as ICG passes from the blood to the bile, which was measured at 359 
in the nomals and decreased to 207 in the shunted animals. 
The ratio of the blood decay slope (K^ ) to the bile ascending slope 
(Kj^ gu) is less than 1,0 in the normal animals and slightly over 1.0 in the 
shunted animals, which is also concurred by the model. A possible expia-
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Figure 9. Comparison of animal and model blood decay curves for both 
normal (A) and shunted (B) cases 
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Figure 10. Comparison of animal and model bile dye accumulation slopes 
for both normal (A) and shunted (B) cases 
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Figure 11. Comparison of animal and model peak times and peak concentra­
tions for both normal (A) and shunted (B) cases 
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Figure 12. Comparison of animal and model bile dye decay slopes for both 
normal (A) and shunted (B) cases 
Table 7. Comparison of special parameters between blood and bile from animal studies and mathemati­
cal model in normal and shunted cases 
CB 
(mg L-1) 
^LB 
(mg L-1) CLB/CB %/KLBU CLBO/CBO 
VLB 
(L) 
I
L
L
 
Normal 43.3* 3338 83.9 0.6282 359^  0.0078^  51 
n = 9 (4.2) (531) (21.3) (0.0459) (126) (0.0024) (15) 
Model 36 4531 125.9 0.7904 570 0.0028 18 
Shunt 60.5* 3907 64.5 1.0203 207 0.0060 86 
n = 2 (4.5) (331) (0.7) (0.6767) (42) (0.0001) (34) 
Model 63.2 6968 110.3 1.1145 310 0.0052 65 
e^an ± (SEM). 
* 
p < 0.02. 
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nation for this is that in the normal case, as the concentration of dye in 
the blood decreases, the concentration of dye in the bile accumulates at a 
rate faster than the blood. However, in the shunted case, due to the de­
creased perfusion of the liver, the rate of decrease of dye in the blood 
is roughly the same as the rate of increase in the bile. 
If it is assumed that is the concentration that would result if 
the calculated dose of dye could be injected directly into the bile 
canalicular space, then dividing C^ go into the dose of given dye will 
yield the volume of the bile canalicular space, V^ g. Furthermore, di­
viding by the mean bile flow, Q^ g, will yield the mean dye residence 
time; i.e., the average time the dye resides within the bile space, 
assuming the dye is homogeneously marking the bile" with respect to time. 
In the present study, it becomes possible to directly estimate the 
bile canalicular volume by a specific experimental method. The implica­
tions of this with regard to the presence or absence of hepatic pathology 
would need to be researched in much greater detail. 
In the study by Wheeler and Ramos (I960), it was stated that in ani­
mals previously given cholecystectomy, anywhere from 6-10 ml of bile could 
be withdrawn from the common bile duct by aspiration at the time of 
catheterization. Although a specific value for the bile canalicular volume 
was not given, the value of 0.32 ml/kg was estimated by dividing the 
median of 8 ml of common duct bile by the mean body weight of the animals 
used in that study. This estimate is certainly Inaccurate since it is 
Improbable that the bile In the bile canalicull could also be evacuated. 
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SUMMARY AND CONCLUSIONS 
Sixteen mongrel dogs were tested for hepatic removal of indocyanine 
green dye in normal animals and animals with portal-caval shunts. Char­
acteristics of blood dye clearance and bile dye accumulation were studied. 
Parameters measured in the blood included cardiac output (CO), dye decay 
rate (Kg), blood volume (V^ ), area under the curve (AUC^ ), and time to 
zero concentration (Tgg). Parameters measured in the bile included mean 
bile flow (Q^ g), peak time (P^ ), peak concentration (P^ i^ g)> area under the 
curve (AUC^ g), and bile concentration at time zero (C^ Bcp)• 
The major findings of this study are as follows: 
1) Response of the mathematical model was similar to the response from 
the studies of normal animals when programmed with initial parameters 
taken from the animal studies. Individual parameters in the mathematical 
model deviated less than 20% from equivalent parameters in the animal 
studies. 
2) The number of animals given portal-caval shunts was too small to 
give indications of significance in parameters that, in theory, should 
have been different, such as peak bile concentration or blood clearance. 
3) The data-handling system worked well in the acquisition of the 
experimental data, but problems did exist, such as clotting in the 
densitometer flow cell and inaccuracies in bile sample dilution. 
4) The variance between animals was too large in certain parameters. 
It is possible that part of this variance may be due to procedure errors 
cited above. The ability to get greater significance and allow an analy-
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sis of variance to eliminate interactions between animals requires not 
only more animals, but repeated measurements within animals. 
5) Aside from the procedural difficulties, there were interesting 
findings in the animal results. Cardiac output decreased two-fold 
(p < 0.01) following a portal-caval shunt. It is entirely possible that 
the acute portal-caval shunt results in the release of vasoactive sub­
stances due to manipulation of the gut during surgery. A chronic study 
may be indicated in this case. 
6) Dye decay rate in the plasma decreased (p < 0.05) which results in 
an increase in area under the blood concentration curve and time to zero 
concentration in the shunted animals. This implies that decreased liver 
perfusion will cause an Increase in the time necessary to clear the dye 
from the blood. 
7) In the shunted case, the mean bile flow was reduced two-fold 
(p < 0.05) while the area under the ascending bile curve increased (p < 
0.05). Since bile flow is directly dependent on the blood perfusion, it 
stands to reason that bile flow would decrease as well. It is difficult 
to state, however, if this decrease is a direct result of the shunt, or a 
direct result of decreased cardiac output and is unaffected by the shunt. 
8) The method with which to measure the volume of the bile canalicular 
space was realized. If no other information is obtained, knowing that the 
bile dye content is decreasing and then measuring the log rate of change 
in dye concentration vs. time will allow computation of the bile space. 
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9) The effects of methoxyflurane-nitrous oxide as an anesthetic on 
the hepatic system appear to be minimal with respect to dye clearance as 
seen by the relatively small differences between the animal data and the 
mathematical model. 
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RECOMMENDATIONS FOR FUTURE WORK 
The present study presents some interesting possibilities for future 
research regarding the effects of portal-caval shunting on the hepatic 
system in general and on the characteristics of ICG removal spcifically: 
1) Repeat studies with more balanced numbers of animals under both 
normal and shunted conditions need to be performed. The results found in 
this study should be investigated more in depth, since several parameters 
were found to be insignificant due to the low number of animals used, 
particularly in the shunt studies. 
2) Studies should be undertaken to ascertain if the dynamics of the 
cardiovascular system as measured by determination of the cardiac output 
are altered acutely during portal-caval shunt surgery. Rapid, multiple 
measurements of cardiac output which are correlated with blood pressures 
before, during, and after surgery would give enough information to discern 
the extent of alteration in cardiovascular performance. 
3) Refinement of the data-handling system employing more accurate 
devices with which to gather experimental data. This includes a fiber­
optic dye measurement system employing a solid-state infrared laser diode 
with which to detect ICG concentration in both blood and bile. A system 
such as this has several advantages in that it would not require a lengthy 
calibration procedure with every experiment and, therefore, would reduce 
the total experimental procedural time by at least two hours. Further­
more, determination of dye concentrations in the blood and the bilé could 
be taken at a greater frequency which would allow the analysis of the data 
to be correlated more accurately. 
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4) Experimentation with the mathematical model should be performed to 
investigate the response of increasing the amount of dye injected and the 
effects on the analysis of the blood decay and bile accumulation curves. 
Further studies might simulate the presence of hepatic pathology by 
affecting the nature of the transfer rate constants. Particularly, the 
effects of hepatic cirrhosis might be studied by decreasing the sinusoid-
hepatocyte transfer rate constant. These investigations could be sub­
stantiated by concurrent animal studies as well. 
5) Chronic studies in animals on the effects of the shunt with re­
spect to ICG removal need to be performed as well to determine the re­
sponse of the dye to abnormal hepatic tissue as opposed to decreased blood 
flow. 
6) Both acute and chronic studies in ICG removal characteristics 
should be performed involving experimentally induced hepatic pathology, 
such as administration of CCI, to induce cirrhosis of the liver. This 
effect may or may not be different from the abnormalities caused by the 
portal-caval shunt. 
7) Finally, it may be interesting to study the specific effects of 
methoxyflurane-nitrous oxide on the cardiac output and hepatic function 
as measured by ICG removal during pre- and post-shunt conditions. 
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EPILOGUE 
What are some of the qualifications of a good teacher? In the first 
place, he sticks to principles and keeps his mind on the goal ... he 
does not qualify every generalization and insert periphrases in every 
other statement. Nor does he pulverize the noble structures of science to 
a dust, until they are no longer beautiful and serve but to repel the 
imaginative spirits that they should attract. ... A good teacher, again, 
is an artist in the use of words; is an advocate in pleading a cause; is a 
judge in weighing evidence; and above all things is an actor holding an 
audience.... 
Knowledge of the technique of surgery is bom only of prolonged 
practice. It seems obvious that it is much wiser and kinder to cultivate 
this art upon the lower animals than upon human beings. To achieve the 
requisite dexterity and facility in handling tissues and instruments de­
mands patience and practice. Although some few appear to find these 
qualifications inherent, most of us can attain them only after persistent 
repetition, concentration, and devotion to the art we desire to possess. 
Fortunately, no study could prove more enthralling and stratifying, and 
simultaneously profitable. As in all surgery, there is sufficient of all 
the elements of satisfaction and pleasure in the performance of these 
procedures, to make the hardest efforts seem easy (Markowitz, Archibald, 
and Downie, 1964, pp. 644, 645). 
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Vivat acadamia, vivant professores; 
Vivat acadamia, vivant professores; 
Vivant membrum quodlibet, vivant membra quaelibet. 
Semper sint in flore! Semper sint in flore! 
Gaudeamus igitur, iuvenes dum sumus; 
Gaudeamus igitur, iuvenes dum sumus; 
Post iucundam iuventutem, post molestam senectutem 
nos habebit humus, nos habebit humus! 
(Christian Wilhelm Kindleben, 1781) 
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APPENDIX A: FORTRAN SOURCE LISTING OF MATHEMATICAL MODEL 
(the subroutine ODES is the library subroutine 
that produces solutions to systems of differen­
tial equations) 
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C LIVER MODEL TEST PROGRAM WRITTEN 12-13-82 
C 
C * FLUID CONCENTRATIONS * 
C * * 
C * X(l) = CONG. IN BLOOD POOL * 
C * X(2) = CONC. IN PORTAL VEIN * 
C * X(3) = CONC. IN LIVER SINUSOIDS * 
X(4) = CONC. IN LIVER HEPATOCYTES * 
X(5) = CONC. IN LIVER BILE * 
* 
C 
C 
C 
C 
C 
C 
C 
C 
PROGRAM LIVMOD 
COMMON /EQNS/ NEQN 
COMMON /PART/ RHO,SIG,DOSE 
COMMON /RATE/ QL,QHA,QP,QLB,KH,KLB 
COMMON /VOLU/ V(5) 
COMMON /TIME/ FT,DELTA,DT 
COMMON /SUMS/ SUM(5) 
REAL X(10),T,DT,ERRLM(2),KH,KLB 
EXTERNAL CLIV,ODES,ODESH 
OPEN(UNIT=5,FILE='LIVIN.NUM',STATUS='OLD') 
0PEN(UNIT=6,FILE='LIVOUT.DAT',STATUS='NEW') 
CALL ENTDAT 
T=0.0 
N=5 
DO 5 1=1,5 
SUM(I)=0.0 
5 CONTINUE 
C 
ERRLM(l)=l.E-5 
ERRLM(2)=l.E-6 
CALL INIVAL(X) 
CALL OUTPUT(X,T) 
DO 10 J=l,FT,DELTA 
CALL ODES(CLIV,X,N,T,T+DELTA,DT,ERRLM,ODESH) 
T=T+DELTA 
CALL OUTPUT(X,T) 
10 CONTINUE 
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WRITE (''s 12) (SUM (I ) , 1=1,5 ) 
12 F0RMAT(4(2X,F9.3),2X,F12.3) 
CLOSE(UNIT=5) 
CLOSE(UNIT=6) 
STOP 
END 
C 
G 
C 
SUBROUTINE OUTPUT(X,T) 
C 
COMMON /EQNS/ NEQN 
COMMON /SUMS/ SUM(5) 
C 
REAL X(5),T,KH,KLB 
C 
DO 15 1=1,5 
IF (X(I).LT.O.O) X(I)=0.0 
15 CONTINUE 
C 
DO 17 1=1,5 
SUM(I)=SUM(I)+X(I)*T 
17 CONTINUE 
C 
WRITE(6,20) T,(X(I), 1=1,NEQN) 
20 F0RMAT(2X,F7.2,5(2X,F9.3)) 
C 
22 RETURN 
END 
C 
C 
C 
SUBROUTINE CLIV(T,X,N,RHS) 
C 
COMMON /RATE/ QL,QHA,QP,QLB,KH,KLB 
COMMON /PART/ RHO.SIG 
COMMON /VOLU/ V(5) 
C 
REAL X(5) ,RHS(5),T,RH0,KH,KLB,SIG 
C 
RHS(1)=((QL*X(3))+(SIG*QP*X(2))-(QHA*X(1))-(QP*X(1)))/V(1) 
RHS(2)=((QP*X(1))-(RH0*QP*X(2))-(SIG*QP*X(2)))/V(2) 
RHS(3)=((RHO*QP*X(2))+(QHA*X(1))-(QL*X(3))-(KH*X(3)))/V(3) 
RHS(4)=((KH*X(3))-(KLB*X(4)))/V(4) 
RHS(5)=((KLB*X(4))-(QLB*X(5)))/V(5) 
C 
RETURN 
END 
C 
C 
C 
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SUBROUTINE ENTDAT 
C 
COMMON /EQNS/ NEQN 
COMMON /PART/ RHO,SIG,DOSE 
COMMON /RATE/ QL,QHA,QP,QLB,KH,KLB 
COMMON /TIME/ FT,DELTA,DT 
COMMON /VOLU/ V(5) 
C 
REAL KH,KLB,RHO,SIG,DOSE 
INTEGER NEQN 
C 
READ(5,*) NEQN 
READ(5,-'0 RHO,DOSE 
READ(5,*) QLP,QLB,KH,KLB 
READ(5,''0 FT,DELTA,DT 
READ(5,*) (V(I), 1=1,5) 
C 
SIG=1.0-RHO 
QP=0.6666667*QLP 
QHA=0.3333333''-QLP 
QL=QHA+RHO"QP 
RETURN 
END 
C 
C 
C 
SUBROUTINE INIVAL(X) 
C 
COMMON /PART/ RHO,SIG,DOSE 
COMMON /VOLU/ V(5) 
REAL X(5),DOSE 
C 
X(1)=D0SE/V(1) 
X(2)=0.0 
X(3)=0.0 
X(4)=0.0 
X(5)=0.0 
C 
RETURN 
END 
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APPENDIX B: FLOW CHARTS OF DATA ACQUISITION PROGRAMS 
DATCAL - dye calibration program 
DATGET - main data acquisition program 
CALOUT - standard curve determination program 
DATOUT - raw data conversion program 
CRDOUT - cardiac output determination program 
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APPENDIX C: BASIC SOURCE LISTINGS OF DATA ACQUISITION 
PROGRAMS WRITTEN FOR PDP-8e/OS8 COMPUTER 
User defined functions Peripheral device 
DIS(X,Y,M$) X-Y plotting oscilloscope 
TIM(W) Clock/timing function 
ADC(C,0) A/D channel function 
SSW(C) Sense switch function 
RLQ(C) Relay control function 
SLN(C) Sense line function 
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10 DIM Y(11),X(11),Z(11),A$(10) 
20 UDEFDIS(X,Y,M$),TIM(W),ADC(C,0),SSW(C) 
30 PRINT TAB (20 );"##### DATA CALIBRATION PROGRAM ###" \ PRINT 
40 E$=DAT$(X) \ PRINT TAB(34);SEG$(E$,1,5)&"/83" 
50 IF K>0 THEN 70 
60 D$="BD" 
70 C$=SEG$(E$,2,2)&SEG$(E$,4,5) \ A$="C"&D$&C$&".DA" 
80 PRINT \ PRINT "ENTER NUMBER OF STANDARDS ( N<=10 )"; \ INPUT N 
90 PRINT \ PRINT TAB(21);"**'-* SET CLOCK TO 30-HZ *****" \ PRINT 
100 PRINT TAB(15);"*** DENSITOMETER FILTER #";F+1;",SCALE FACTOR";F+2; 
110 FOR J=2 TO N+1 
120 PRINT \ PRINT "ENTER CONCENTRATION FOR THIS STANDARD (PRESS RETURN 
TO ZERO)"; 
130 INPUT X(J) \ IF X(J)<>0 THEN 140 \ GO TO 480 
140 PRINT \ PRINT "PRESS RETURN TO BEGIN SAMPLE RECORD"; \ INPUT B$ 
150 W=TIM(-30) \ REM 30-HZ CLOCK RETURNS TIME IN SECONDS 
160 PRINT \ PRINT "WAITING FOR SAMPLE TO ARRIVE" 170 IF K=1 THEN 240 
180 L=ADC(8,0) 
190 IF L<1 THEN 210 
200 GO TO 180 
210 L=ADG(8,0) 
220 IF L>0 THEN 240 
230 GO TO 210 
240 FOR 1=1 TO 10 
250 W=TIM(0) \ Z(I)=ADC(8,0) 
260 IF Z(I)>=0 THEN 280 
270 Z(I)=0 
280 PRINT I,Z(I) 
290 W=TIM(30) 
300 NEXT I \ M=0 
310 PRINT \ PRINT "DO YOU WISH TO OMIT DATA (Y/N)"; \ INPUT B$ 
320 IF B$="N" THEN 350 
330 IF B$="Y" THEN 370 
340 GO TO 310 
350 IF M>0 THEN 400 
360 A=1 \ B=10 \ GO TO 400 
370 M=1 \ PRINT \ PRINT "ENTER RANGE OF NUMBERS TO BE SAVED"; \ INPUT A,B 
380 R=0 \ FOR I=A TO B \ R=R+Z(I) \ PRINT I,Z(I),R \ NEXT I \ PRINT 
390 PRINT J-1,X(J);"MG/L",R/(B-A+1),"AVERAGE OF N=";B-A+1;"P0INTS" \ GO 
TO 310 
400 R=0 \ FOR I=A TO B \ R=R+Z(I) \ NEXT I \ PRINT \ PRINT \ 
Y(J)=R/(B-A+1) 
410 PRINT J-1,X(J);"MG/L",Y(J),"FINAL AVERAGE OF N=";B-A+1;"POINTS" 
420 PRINT \ PRINT "PRESS RETURN TO CONTINUE CALIBRATION ROUTINE"; \ 
INPUT B$ 
430 NEXT J \ PRINT \ PRINT \ FILEVN#1:A$ 
440 PRINT TAB(10);"*** STORING DATA IN FILE ";A$;" ***" 
450 PRINT \ PRINT "NUMBER OF STANDARDS ST0RED=";N+1 \ PRINT #1:N+1 \ 
PRINT 
460 FOR J=0 TO N+1 \ PRINT X(J);"MG/L",Y(J) \ PRINT #1:X(J),Y(J) \ NEXT J 
470 CLOSE #1 \ GO TO 540 
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480 PRINT \ PRINT "ZERO ADJUST FOR DENSITOMETER" 
490 PRINT \ PRINT "TOGGLE SENSE SWITCH 2 TO CONTINUE" 
500 W=TIM(0) \ L=ADC(8,0) 
510 IF SSW(2)<0 THEN 120 
520 PRINT L, 
530 W=TIM(15) \ GO TO 500 
540 IF K>0 THEN 600 
550 PRINT \ PRINT "DO YOU HAVE BILE STANDARDS ALSO"; \ INPUT B$ 
560 PRINT \ PRINT \ K=1 \ D$="BL" \ F=2 
570 IF B$="Y" THEN 10 
580 IF B$="N" THEN 600 
590 GO TO 550 
600 PRINT \ PRINT \ CHAIN "SYS:DATGET.SV" \ END 
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10 REM \ REM \ REM 
20 DIM A$(10),C$(10),X(1200),Y(270),N(60),U(60) 
30 UDEFDIS(X,Y,M$),TIM(W),ADC(C,0),SSW(C),RLY(C),SLN(C) 
40 PRINT TAB(20) ;"#### DATA ACQUISITION PROGRAM ####" \ PRINT 
50 D$=DAT$(X) \ PRINT TAB(34);SEG$(D$,1,5)&"/83" \ PRINT \ PRINT 
60 F$=SEG$(D$,2,2)&SEG$(D$,4,5) \ A$="BB"&F$&".DA" \ C$="HRT"&F$&".DA" 
70 PRINT \ PRINT "ENTER WEIGHT (LBS)"; \ INPUT HI 
80 PRINT \ PRINT "ENTER HEMATOCRIT"; \ INPUT H2 
90 PRINT \ PRINT "ENTER SPACING FOR PLOT"; \ INPUT M \ PRINT 
100 PRINT \ PRINT "ENTER SAMPLE TO DENSITOMETER TIME DELAY"; \ INPUT A 
110 PRINT \ PRINT "ENTER DYE INJECTION TIME DELAY"; \ INPUT B \ PRINT 
120 PRINT TAB(15) SET EXTERNAL CLOCK TO 30-HZ FREQUENCY *****" \ 
PRINT 
130 PRINT TAB(18);"-"W: DENSITOMETER FILTER # 1, SCALE FACTOR 2 ***" \ 
PRINT 
140 R=RLY(1) \ PRINT "RELAY(l) ENABLED...BILE FLOW ESTABLISHED" \ PRINT 
150 R=RLY(-2) \ PRINT "RELAY(2) DISABLED...TUBE RESET READY" \ PRINT 
160 PRINT "DROP COUNTER CHECK...TOGGLE SENSE SWITCH 2 TO CONTINUE" \ N=0 
170 PRINT "SENSE SWITCH 1 CONTROLS BILE RELAY FOR ADJUSTMENT" \ PRINT 
180 IF SLN(1)<0 THEN 220 
190 IF SSW(2)<0 THEN 270 
200 R=RLY((SSW(l)+.5)*2) 
210 GO TO 180 
220 N=N+1 \ PRINT N, 
230 IF N=200 THEN 260 
240 IF SLN(1)<>0 THEN 240 
250 GO TO 180 
260 R=RLY(2) \ W=TIM(20) \ R=RLY(-2) \ N=0 \ GO TO 180 
270 IF SSW(2)<>0 THEN 270 
280 PRINT \ PRINT "ZERO LEVEL CHECK... TOGGLE SENSE SWITCH 2 TO CONTINUE" 
290 GOSUB 1220 
300 H3=H1*.453592 \ H4=H3/25 \ PRINT \ PRINT \ PRINT 
310 PRINT "ANIMAL WEIGHT =";H1;"LBS 0R";H3;"KG" \ PRINT 
320 PRINT "DYE DOSAGE FOR THIS ANIMAL IS";H3/25;"ML (@ 25 MG/ML)" \ PRINT 
330 PRINT \ PRINT "PRESS RETURN TO BEGIN 60-SEC. COUNTDOWN"; \ INPUT B$ 
340 IF SSW(1)<0 THEN 370 \ IF SSW(2)<0 THEN 370 \ IF SSW(3)<0 THEN 370 
350 IF SSW(4)<0 THEN 370 \ IF SSW(5)<0 THEN 370 \ IF SSW(6)<0 THEN 370 
360 GO TO 390 
370 PRINT \ PRINT "$$$$$ COUNTDOWN ABORTED! CHECK SENSE SWITCHES!! $$$$$" 
380 GO TO 330 
390 PRINT \ 1=60 \ D=DIS(0,-1,"") \ K=0 
400 W=TIM(0) 
410 IF 1=30 THEN 470 
420 IF 1=25 THEN 500 
430 IF 1=10 THEN 550 
440 PRINT "T-MINUS:";I \ 1=1-1 
450 W=TIM(30) 
460 GO TO 400 
470 PRINT \ PRINT "T-MINUS:";I,"BILE FLOW CUTOFF NOW!" \ R=RLY(-1) 
480 PRINT \ 1=1-1 \ W=TIM(30) 
490 GO TO 400 
500 FOR J=30 TO 300 STEP 30 \ GOSUB 1300 
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lOOO PRINT "*** DENSITOMETER FILTER # 3, SCALE FACTOR 4 ***" \ PRINT 
1010 GO TO 710 
1020 REM FILE OUTPUTS AND PROGRAM END 
1030 R=RLY(-1) \ R=RLY(-2) 
1040 FILEVN#2:C$ 
1050 PRINT TAB(IO);"*** STORING DATA IN FILE ";C$;" ***" \ PRINT 
1060 PRINT G(0),A,S \ PRINT #2:G(0),A,S \ PRINT 
1070 FOR J=1 TO S \ PRINT X(J), \ PRINT #2:X(J) \ NEXT J 
1080 CLOSE #2 \ PRINT \ PRINT 
1090 PRINT "PRESS RETURN FOR BLOOD & BILE DATA"; \ INPUT B$ \ PRINT 
1100 FILEVN#1:A$ 
1110 PRINT TAB(IO);"""" STORING DATA IN FILE ";A$;" ***" \ PRINT 
1120 PRINT "FINAL TIME =";I;"MIN","# TUBES =";T-1,"# BILE SAMPLES =";V-1 
1130 PRINT \ PRINT "ANIMAL WEIGHT =";H3;"KG",,"HEMATOCRIT =";H2 
1140 PRINT #1:H3,H2,I,T-1,V-1 \ PRINT \ PRINT 
1150 PRINT "PRESS RETURN FOR BLOOD VALUES" \ INPUT B$ \ PRINT 
1160 FOR J=1 TO I \ PRINT Y(J), \ PRINT #1:Y(J) \ NEXT J \ PRINT 
1170 PRINT "PRESS RETURN FOR DROP TOTALS" \ INPUT B$ \ PRINT 
1180 FOR J=1 TO T-1 \ PRINT N(J), \ PRINT #1:N(J) \ NEXT J \ PRINT 
1190 PRINT "PRESS RETURN FOR BILE VALUES" \ INPUT B$ \ PRINT 
1200 FOR J=1 TO V-1 \ PRINT U(J), \ PRINT #1:U(J) \ NEXT J \ CLOSE #1 
1210 PRINT \ PRINT \ PRINT \ GO TO 1540 
1220 Z=ADC(8,0) \ PRINT Z, \ FOR A7=l TO 15 
1230 IF J=0 THEN 1250 \ IF SLN(1)=0 THEN 1240 \ GOSUB 1270 
1240 IF W-J>=55 THEN 1260 
1250 W=TIM(0) \ W=TIM(1) \ NEXT A7 \ IF SSW(2)<0 THEN 1260 \ GO TO 1220 
1260 PRINT \ PRINT \ A8=l \ RETURN 
1270 N=N+1 
1280 IF SLN(1)<>0 THEN 1280 
1290 RETURN 
1300 Z=ADC(8,0) 
1310 IF Z>=0 THEN 1330 
1320 Z=0 
1330 D=DIS(K,Z*.5,"") \ K=K+1 \ RETURN 
1340 S=0 \ P=M \ PRINT \ PRINT "WAITING FOR APPEARANCE OF DYE" \ PRINT 
1350 R=RLY(3) 
1360 Z=ADC(8,0) 
1370 W=TIM(1) 
1380 IF Z<2 THEN 1400 
1390 GO TO 1360 
1400 Z=ADC(8,0) 
1410 W=TIM(1) 
1420 IF Z>5 THEN 1440 
1430 GO TO 1400 
1440 G(0)=TIM(0) \ PRINT "START DATA SAMPLING" 
1450 FOR Q=1 TO 1200 
1460 IF W=59 THEN 1530 
1470 Z=ADC(8,0) 
1480 IF Z>=0 THEN 1500 
1490 Z=0 
1500 IF QOP THEN 1520 
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1510 D=DIS(K,Z*.5,"") \ K=K+1 \ P=P+M 
1520 S=S+1 \ X(S)=Z \ W=TIM(Q) \ NEXT Q 
1530 R=RLY(-3) \ RETURN 
1540 PRINT TAB (20);"### MAIN PROGRAM HAS ENDED ###" \ PRINT \ PRINT 
1550 PRINT \ PRINT TAB (14);"### PRESS RETURN TO BEGIN DATA OUTPUT 
#####" 
1560 INPUT B$ \ PRINT \ PRINT \ PRINT \ PRINT \ PRINT 
1570 CHAIN "SYS:CALOUT.SV" \ END 
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10 DIM A$(10),X(11),Y(11) 
20 PRINT TAB (20 );"### CALIBRATION FACTORS OUTPUT PROGRAM ###" \ 
PRINT 
30 PRINT \ PRINT "DO YOU WANT TODAY'S DATA"; \ INPUT B$ \ PRINT 
40 IF B$="Y" THEN 60 \ IF B$="N" THEN 50 \ GO TO 30 
50 PRINT "ENTER EXPERIMENT DATE"; \ INPUT F$ \ PRINT \ PRINT \ GO TO 70 
60 F$=DAT$(X) 
70 PRINT TAB(39);SEG$(F$,l,5)6c"/83" \ PRINT \ PRINT 
80 IF T>0 THEN 100 
90 D$="BD" 
100 C$=SEG$(F$,2,2)&SEG$(F$,4,5) \ A$="C"&D$&C$&".DA" \ FILEN#1:A$ 
110 PRINT TAB(10);"*** OPENING FILE C"&D$&C$&".DA FOR DATA INPUT ***" 
120 INPUT #1:N \ PRINT \ PRINT "THIS FILE HAD";N;"STANDARDS" \ PRINT 
130 A=0 \ B=0 \ C=0 \ D=0 \ E=0 
140 FOR J=0 TO N 
150 INPUT #1:X(J),Y(J) 
160 PRINT X(J);;"MG/L",Y(J) 
170 A=A+X(J) \ B=B+X(J)2 \ C=C+X(J)*Y(J) \ D=D+Y(J)2 \ E=E+Y(J) 
180 NEXT J \ CLOSE #1 
190 PRINT \ PRINT "*** LINEAR REGRESSION ANALYSIS \ PRINT 
200 L=C-A*E/N \ K=B-A2/N \ M=D-E2/N \ S=L/K \ I=(E-S*A)/N \ R=L/SQR(K*M) 
210 PRINT TAB(10);"SLOPE =";S \ PRINT \ PRINT TAB(IO);"INTERCEPT =";I 
220 PRINT \ PRINT TAB(10);"CORRELATION COEFFICIENT =";R \ PRINT 
230 A$="L"&D$&C$&".DA" \ PRINT "STORING SLOPE/INTERCEPT VALUES IN FILE " 
&A$ 
240 FILEVN#2:A$ \ PRINT #2:S,I \ CLOSE #2 \ PRINT \ PRINT 
250 PRINT "***** OPEN PDP-11 FILE '"&A$&"T' NOW *****" \ INPUT B$ 
260 PRINT \ PRINT "PRESS RETURN FOR DATA" \ INPUT B$ \ PRINT 
270 PRINT S,I,R \ PRINT 
280 FOR J=1 TO N \ PRINT X(J);;"MG/L",Y(J),(Y(J)-I)/S \ NEXT J 
290 PRINT \ PRINT "***** CLOSE PDP-11 FILE *****" \ INPUT B$ 
300 PRINT \ PRINT \ IF T>0 THEN 360 
310 PRINT \ PRINT "DO YOU HAVE A BILE STANDARDS FILE"; \ INPUT B$ \ 
PRINT 
320 T=1 \ D$="BL" 
330 IF B$="Y" THEN 70 
340 IF B$="N" THEN 360 
350 GO TO 310 
360 PRINT \ PRINT \ PRINT \ CHAIN "DATOUT.SV" 
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10 DIM A$(10),Y(270),N(60),U(60) 
20 UDEFDIS(X,Y,M$) 
30 PRINT TAB(20) ;"##### DATA OUTPUT PROGRAM ###" \ PRINT 
40 PRINT \ PRINT "DO YOU WANT TODAY'S DATA (Y/N)"; \ INPUT B$ \ PRINT 
50 IF B$="Y" THEN 70 \ IF B$="N" THEN 60 \ GO TO 40 
60 PRINT "ENTER EXPERIMENT DATE"; \ INPUT D$ \ GO TO 80 
70 D$=DAT$(X) 
80 PRINT TAB(31);SEG$(D$,1,5)&"/83" \ PRINT \ PRINT 
90 C$=SEG$(D$,2,2)&SEG$(D$,4,5) \ A$="LBD"&C$&".DA" \ FILEN#2:A$ \ INPUT 
#2:SO,10 
100 CLOSE #2 \ A$="LBL"&C$&".DA" \ FILEN#3:A$ \ INPUT #3:SI,II \ CLOSE #3 
110 PRINT "SLOPE/INTERCEPT DATA: BLOOD =";SO;IO;" BILE =";S1;I1 \ PRINT 
120 A$="BB"&C$&".DA" \ FILEN#1:A$ 
130 PRINT TAB(IO) OPENING FILE ";A$;" FOR DATA INPUT \ PRINT 
140 INPUT #1:H3,H2 \ PRINT "ANIMAL WEIGHT =";H3;"KG",,"HEMATOCRIT =";H2 
150 INPUT #1:1,T,V \ PRINT \ PRINT "THIS EXPERIMENT RAN";I;"MINUTES" 
160 PRINT \ PRINT "IT HAD";T;"DROP TOTALS AND";V;"BILE SAMPLES" 
170 FOR J=1 TO I \ INPUT #1:Y \ Y(J)=(Y-I0)/S0 \ IF Y(J)>=0 THEN 180 \ 
Y(J)=0 
180 NEXT J \ PRINT \ PRINT \ PRINT "BLOOD DYE DATA IS NOW LOADED" \ PRINT 
190 PRINT "ENTER X-Y SCALE FACTORS"; \ INPUT XI,Y1 \ PRINT 
200 PRINT "PLOTTING BLOOD DYE DATA NOW..." \ PRINT 
210 PRINT "ENTER FINAL TIME <";I; \ INPUT Z \ IF Z>I THEN 210 \ PRINT 
220 D=DIS(0,-1,"") \ FOR J=1 TO Z \ D=DIS(J*X1,Y(J)*Y1,"") \ NEXT J 
230 PRINT "IS THIS ACCEPTABLE"; \ INPUT B$ \ PRINT \ IF B$="Y" THEN 250 
240 IF B$="N" THEN 190 \ GO TO 230 
250 PRINT \ PRINT "***** OPEN PDP-11 FILE 'BLD"&C$&".DAT' NOW *****" 
260 INPUT B$ \ PRINT \ PRINT "PRESS RETURN FOR BLOOD VALUES" \ INPUT B$ 
270 FOR J=1 TO Z \ PRINT J,Y(J) \ NEXT J 
280 PRINT \ PRINT "***** CLOSE PDP-11 FILE *****" \ INPUT B$ 
290 FOR J=1 TO T \ INPUT #1:N \ N(J)=N/35 \ IF N(J)>=0 THEN 300 \ N(J)=0 
300 NEXT J \ PRINT \ PRINT \ PRINT "BILE DROP DATA IS NOW LOADED" \ PRINT 
310 PRINT "ENTER X-Y SCALE FACTORS"; \ INPUT XI,Y1 \ PRINT 
320 PRINT "PLOTTING BILE DROP DATA NOW..." \ PRINT \ D=DIS(0,-1,"") 
330 FOR J=5 TO T''5 STEP 5 \ D=DIS(J*Xl/5 ,N(J/5)*Y1,"") \ NEXT J 
340 PRINT "IS THIS ACCEPTABLE"; \ INPUT B$ \ PRINT \ IF B$="Y" THEN 360 
350 IF B$="N" THEN 310 \ GO TO 340 
360 PRINT \ PRINT "***** OPEN PDP-11 FILE 'DPS"&C$&".DAT' NOW *****" 
370 INPUT B$ \ PRINT \ PRINT "PRESS RETURN FOR DROP VOLUMES"; \ INPUT B$ 
380 FOR J=5 TO T^ 5 STEP 5 \ PRINT J,N(J/5) \ NEXT J 
390 PRINT \ PRINT "***** CLOSE PDP-11 FILE *****" \ INPUT B$ 
400 FOR J=1 TO V \ INPUT #1:U \ U(J)=(U-I1)/S1*125 \ IF U(J)>=0 THEN 410 
\ U(J)=0 
410 NEXT J \ PRINT \ PRINT \ PRINT "BILE DYE DATA IS NOW LOADED" \ PRINT 
420 PRINT "ENTER X-Y SCALE FACTORS"; \ INPUT XI,Y1 \ PRINT 
430 PRINT "PLOTTING BILE DYE DATA NOW..." \ PRINT \ D=DIS(0,-1,"") 
440 FOR J=5 TO V"5 STEP 5 \ D=DIS(J*Xl/5,U(J/5)*Y1,"") \ NEXT J 
450 PRINT "IS THIS ACCEPTABLE"; \ INPUT B$ \ PRINT \ IF B$="Y" THEN 470 
460 IF B$="N" THEN 420 \ GO TO 450 
470 PRINT \ PRINT "***** OPEN PDP-11 FILE 'BIL"&C$&".DAT' NOW *****" 
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480 INPUT B$ \ PRINT \ PRINT "PRESS RETURN FOR BILE VALUES " \ INPUT B$ 
490 FOR J=5 TO V*5 STEP 5 \ PRINT J,U(J/5) \ NEXT J 
500 PRINT \ PRINT "-if**** CLOSE PDP-11 FILE *****" \ INPUT B$ \ CLOSE #1 
510 PRINT \ PRINT \ PRINT \ CHAIN "CRDOUT.SV" 
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10 DIM A$(10),Y(1600) 
20 UDEFDIS(X,Y,M$) 
30 PRINT TAB (15 );"### CARDIAC OUTPUT DATA OUTPUT PROGRAM ###" \ PRINT 
40 PRINT "DO YOU WANT TODAY'S DATA (Y/N)"; \ INPUT B$ \ PRINT 
50 IF B$="Y" THEN 70 \ IF B$="N" THEN 60 \ GO TO 40 
60 PRINT "ENTER EXPERIMENT DATE"; \ INPUT D$ \ PRINT \ PRINT \ GO TO 80 
70 D$=DAT$(X) 
80 PRINT TAB(34);SEG$(D$,l,5)&"/83" \ PRINT \ PRINT 
90 C$=SEG$(D$,2,2)&SEG$(D$,4,5) \ A$="LBD"&C$&".DA" \ FILEN#2:A$ 
100 INPUT #2:S,I \ CLOSE #2 \ PRINT "BLOOD DATA SLOPE =";S;" INTERCEPT 
=";I 
110 A$="HRT"&C$&".DA" \ FILEN#1:A$ 
120 PRINT \ PRINT \ PRINT TAB(10);"*** OPENING FILE ";A$;" FOR DATA 
INPUT ***" 
130 PRINT \ INPUT //1:G(0),A,Q \ H=30*INT(G(0)-A+.5) 
140 IF H>=0 THEN 150 \ H=0 
150 PRINT G(0),A,Q,H \ PRINT \ M0=0 
160 Q=Q+H \ PRINT "DYE CURVE BEGAN";G(0)-A;"SECONDS AFTER INJECTION" \ 
PRINT 
170 FOR J=H TO Q \ INPUT #1:Y \ Y(J)=(Y-I)/S \ IF Y(J)>=0 THEN 180 \ 
Y(J)=0 
180 IF J=H THEN 200 \ IF Y(J)<=MO THEN 200 \ IF Y (J) >512 THEN 200 
190 MO=Y(J) \ TO=J 
200 NEXT J \ PRINT \ CLOSE #1 
210 PRINT \ PRINT "MAXIMUM VALUE =";MO;"AT TIME";T0/3O;"SECONDS" \ PRINT 
220 PRINT \ PRINT "ENTER X,Y-SPACING FACTORS"; \ INPUT V,U 
230 PRINT "PLOTTING AT AN EFFECTIVE SAMPLE RATE OF";30/V;"-HZ" 
240 D=DIS(0,-1,"") 
250 FOR J=0 TO Q STEP V \ DO=DIS(J/V,Y(J)*U,"") \ NEXT J 
260 PRINT \ PRINT "DO YOU WANT TO SEE ANOTHER DATA PLOT (Y/N)"; \ 
INPUT B$ 
270 IF B$="Y" THEN 220 
280 IF B$="N" THEN 300 
290 GO TO 260 
300 PRINT \ PRINT "***** LINEAR REGRESSION ANALYSIS *****" \ Z=.93 \ 
W=.6 
310 PRINT \ PRINT "INITIAL LIMITS FOR DECAY CURVE: UPPER =";Z;" LOWER 
=";W 
320 PRINT \ A=0 \ B=0 \ C=0 \ D=0 \ E=0 \ N=0 
330 FOR J=TO TO Q \ IF Y(J)<=Z*MO THEN 340 \ NEXT J 
340 X0=INT(J/V+.5)*V \ FOR J=X0 TO Q \ IF Y(J)<=W*MO THEN 360 
350 GOSUB 530 \ NEXT J 
360 X1=INT(J/V+.5)*V \ L=C-A*E/N \ K=B-A2/N \ M=D-E2/N 
370 S=L/K \ I=(E-S*A)/N \ R=L/SQR(K*M) 
380 PRINT "REGRESSION COMPLETE FOR RANGE";X0/30;"TO";Xl/30;"SECONDS" 
390 PRINT \ PRINT TAB( 10) ; "SLOPE =";S \ PRINT TAB(10);"INTERCEPT =";I 
400 PRINT TAB(10);"CORRELATION COEFFICIENT =";R \ PRINT 
410 PRINT "NOW INDICATING RANGE TESTED FOR LINEARITY" \ PRINT 
420 D0=DIS(X0/V,Y(X0)*U,"<—") \ D0=DIS(X1/V,Y(X1)*U,"<--") 
430 PRINT "IS THIS ACCEPTABLE"; \ INPUT B$ \ IF B$="Y" THEN 460 
440 IF B$="N" THEN 450 \ GO TO 430 
450 PRINT \ PRINT "ENTER NEW UPPER/LOWER LIMITS"; \ INPUT Z,W \ GO TO 320 
460 PRINT \ PRINT "REPLOTING DATA AT EFFECTIVE SAMPLE RATE 0F";30/V;"-HZ" 
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470 D0=DIS(0,-1,"") \ FOR J=0 TO Q STEP V \ DO=DIS(J/V,Y(J)*U,"") \ 
NEXT J 
480 DO=DIS(XO/V,Y(XO)*U,\ D0=DIS(X1/V,Y(X1)*U,"<—") 
490 FOR J=XO TO Q \ Y(J)=EXP(I)*EXP(S*J/30) \ IF Y(J)>=0 THEN 500 \ 
Y(J)=0 
500 NEXT J 
510 FOR J=X0 TO Q STEP V \ D0=DIS(J/V,Y(J)*U,"") \ NEXT J \ PRINT \ 
PRINT 
520 PRINT "PRESS RETURN TO CONTINUE"; \ INPUT B$ \ PRINT \ GO TO 560 
530 X=J/30 \ Y=LOG(Y(J)) \ N=N+1 
540 A=A+X \ B=B+X2 \ C=C+X*Y \ D=D+Y2 \ E=E+Y 
550 RETURN 
560 A$="BB"&C$&".DA" \ FILEN#2:A$ \ INPUT #2:H3 \ CLOSE #2 
570 PRINT \ PRINT "CALCULATIONS TO FOLLOW;" \ X=0 \ Y=0 \ Y1=0 
580 FOR J=0 TO Q \ X=X4-(J/30)*Y(J) \ Y=Y+Y(J) \ Yl=Yl+(Y(J)/30) \ NEXT J 
590 Y2=EXP(I)*EXP(S*J/30) \ IF Y2>=0 THEN 600 \ Y2=0 
600 X=X+(J/30)*Y2 \ Y=Y+Y2 \ Yl=Yl+(Y2/30) \ IF Y2<=2.47875E-03*M0 
THEN 620 
610 J=J+1 \ GO TO 590 
620 T1=X/Y \ C0=H3*60/Y1 \ C1=CO*1000*T1/60 
630 PRINT \ PRINT TAB(25);"FINAL TIME CALCULATED =";J/30;"SECONDS" 
640 PRINT \ PRINT TAB(25);"TOTAL DYE INJECTED =";H3;"MG" 
650 PRINT \ PRINT TAB(25);"AREA UNDER CURVE =";Y1;"MG-S/L" \ PRINT \ 
PRINT 
660 PRINT \ PRINT TAB(25);"CARDIAC OUTPUT =";C0;"L/MIN" 
670 PRINT TAB(25);"MEAN TRANSIT TIME =";T1;"SECONDS" 
680 PRINT TAB(25);"CENTRAL BLOOD VOLUME =";C1;"ML" 
690 PRINT \ PRINT \ PRINT "***** OPEN PDP-11 FILE 'CAR"&C$&".DAT' NOW 
700 INPUT B$ \ PRINT \ PRINT "PRESS RETURN FOR DATA" \ INPUT B$ \ PRINT 
710 PRINT \ PRINT J/30,H3,Yl \ PRINT \ PRINT C0,T1,C1 \ PRINT \ PRINT 
720 FOR J=0 TO Q \ PRINT Y(J), \ NEXT J 
730 PRINT \ PRINT "***** CLOSE PDP-11 FILE *****" \ INPUT B$ \ PRINT 
740 PRINT \ PRINT \ PRINT TAB (25);"## PROGRAM SEQUENCE COMPLETED 
750 END 
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APPENDIX D: SURGICAL PROCEDURE 
The animal was prepared for midline laparotomy and femoral cutdown 
and then placed on the surgical table in dorsal recumbancy. Body tempera­
ture was maintained using a heating pad placed underneath the animal and 
was monitored using an esophageal thermistor and a YSI tele-thermometer 
(Yellow Springs Instrument Co., Inc., Yellow Springs, OH). Needle elec­
trodes were placed in the extremities such that a Lead II EGG could be 
obtained. 
After application of surgical drapes, a midline incision was made 
using an electrosurgical device (Cameron-Miller Surgical Instrument Co., 
Chicago, IL). Entrance into the peritoneal cavity was expedited by the 
use of electrocautery to cut and seal all tiny blood vessels and results 
in greatly reducing any subsequent hemorrhage later when the animal will 
be given heparin. 
Upon completion of the abdominal opening and insertion of a Balfour 
retractor, the right lateral, right central, and caudate lobes of the 
liver are gently raised and reflected cranially using moistened sponges 
held on sponge forceps. This results in adequate exposure of the gall 
bladder and cystic duct to allow for ligation of the cystic duct. Expo­
sure is further enhanced by placing a ribbon retractor wrapped in a 
saline-moistened lap sponge over the exterior of the duodenum and pyloric 
antrum and then applying gentle pressure caudally. A small tunnel under 
the cystic duct medial to the body of the gall bladder and the entrance to 
the common bile duct is then made using bile duct forceps. A length of 
umbilical tape is passed around the cystic duct and the duct is then 
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constricted by placing a plastic retainer over the free ends of the tape, 
passing the retainer down to the duct, then securing the retainer with a 
hemostat while applying backward pressure on the tape. This results in a 
constriction that will remain in place for the duration of the experiment 
(Figure 13). Care must be taken to avoid impaling the hepatic capsule 
during the ligation of the cystic duct. However, when this occurred the 
wound was cauterized carefully and covered with a strip of Gelfoam sponge 
(The Upjohn Company, Kalamazoo, MI) when the procedure had been completed. 
The ribbon retractor is withdrawn slightly more caudal to expose the 
area of the common bile duct for cannulation. The surrounding connective 
tissue is carefully removed from the vicinity of the common duct using the 
bile duct forceps and employing cautery when needed to control hemorrhage 
in the fatty deposits of the surrounding tissue. Two lengths of 3-0 silk 
suture are then placed, but not tied, around the duct to be used as stay 
sutures (Figure 14). Immediately prior to cannulation, the caudal stay 
suture is tied as close to the duodenum as possible, then a small cut is 
made in the common duct with iris scissors. A cannula of 1.57 mm ID 
Silastic tubing (Cat. #602-205, Dow Coming, Inc., Midland, MI) with a 
2.0 cm plastic tubing connector of similar diameter on the duct end is 
inserted into the duct using a cathetér introducer. Once in place, the 
cranial stay suture is tied over the connector in the duct to secure the 
cannula (Figure 15). Bile usually begins to flow immediately once the 
cranial stay suture has been tied. 
The procedure for portal-caval shunt (Eck fistula) has been described 
previously (Antol, 1980; Markowitz et al., 1964). The surgical approach 
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in these experiments was still made from the midline incision rather than 
the more complex abdominal incision described by Markowitz et al. Follow­
ing completion of the shunt, the vessels were wrapped in Gelfoam sponge to 
assist in hemostasis of the suture lines before the spleen and intestines 
were replaced in the abdominal cavity prior to closing. 
In those experiments requiring cannulation of the hepatic vein, the 
left common hepatic vein was cannulated according to Shoemaker et al. 
(1959) using a length of PE-190 tubing previously fitted with an 18 ga. 
luer hub. The cannula was anchored to the abdominal wall with 3-0 silk 
suture to prevent accidental withdrawal of the cannula from the insertion 
site. 
The femoral cutdown to allow introduction of arterial and venous 
cannulas was performed in the usual manner with the femoral artery and 
vein being exposed from a point distal to the deep inguinal ring to a 
point proximal to the knee. When the surrounding connective tissue had 
been cleared, a cannula of 1.57 mm ID Silastic tubing was introduced into 
the femoral artery and advanced into the abdominal and thoracic aorta 
until coming to rest near the aortic valve, as indicated by the arterial 
blood pressure waveform. In a similar manner, a cannula of 3.35 mm ID 
Silastic tubing (Cat. #601-335) was introduced into the femoral vein and 
advanced into the inferior vena cava until coming to rest near the right 
atrium, as indicated by the venous blood pressure waveform. Both cannulas 
were then secured with 3-0 silk suture. 
Upon completion of both procedures, the incisions were drawn together 
and closed with towel clamps. A circulating warm water pad was placed 
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over the animal and the pad was covered with two layers of surgical 
drapes. In the latter experiments involving the portal-caval shunt pro­
cedure, the bladder of each animal was catheterized using a 50 cm 5F 
cannula with the urine being channeled through rubber tubing into a floor 
drain. 
108 
Figure 13. Photograph of cystic duct ligation showing gall bladder (G), 
umbilical tape (U), plastic retainer (R), and restraining 
hemostat (H) 
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Figure 14. Photograph of bile duct before cannulatlon showing stay 
sutures (S), bile duct (B), and duodenum (D) 
Figure 15. Photograph of bile duct after cannulation showing bile duct 
(B), duodenum (D), plastic tubing connector (T) tied in 
place, and the cannula (C) 
I l l  
APPENDIX E: RAW DATA FROM ANIMAL STUDIES WITH 
MEANS AND STANDARD ERRORS OF THE MEAN 
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Table 8. Body weights, hematocrits, and cardiac outputs for both animal 
groups 
BW Hematocrit Cardiac output 
Animal # Type (kg) (%) (L min-1 kg-1) 
Group 1 
502 Normal 17.2 36 
504 Normal 17.2 42 0.130 
518 Normal 17.2 35 0.240 
520 Normal 22.7 52 0.173 
523 Normal 19.1 51 0.162 
525 Normal 20.0 36 0.171 
527 Normal 19.5 44 0.117 
601 Normal 16.3 36 0.117 
603 Normal 18.6 39 0.138 
Mean 18.6 41 0.156 
(SEM) (0.7) (2) (0.014) 
805 Shunt 20.4 48 0.065 
810 Shunt 18.6 50 0.080 
Mean 19.5 49 0.073* 
(SEM) a (0.9) (1) (0.008) 
Group 2 
817 Normal 23.6 43 0.104 
819 Normal 22.2 41 0.216 
822 Normal 21.8 50 0.124 
Mean 22.5 45 0.148 
(SEM) (0.5) (3) (0.034) 
831 Shunt 20.0 47 0.160 
907 Shunt 19.5 52 0.191 
Mean 19.8 50 0.176 
(SEM) (0.2) (2) (0.016) 
S^EM = standard error of the mean. 
* 
p < 0.01. 
Table 9. Blood results for hepatic uptake of ICG in normal and shunted animals in Group 1 
Animal # In (Cgg) 
BV 
(L) 
BV/BW 
(L kg-1) 
KB 
(min~L) 
01 
(L min~^ ) 
AUCB 
(mg min L~^ ) 
TBCO 
(min) 
502 2.735 1.74 0.101 -0.0964 -0.168 1121 25 
504 2.338 2.86 0.166 -0.0827 -0.236 897 25 
518 2.396 2.41 0.140 -0.0717 -0.173 1313 30 
520 2.790 2.91 0.128 -0.0861 -0.250 1561 30 
523 2.500 3.20 0.168 -0.0723 -0.231 1622 35 
525 2.631 2.25 0.112 -0.1345 -0.302 546 20 
527 3.024 1.69 0.087 -0.0725 -0.123 2774 40 
601 2.821 1.52 0.093 -0.1041 -0.158 1104 25 
603 2.432 2.68 0.144 -0.0801 -0.214 1185 30 
Mean 2.630 2.36 0.127 -0.0889 -0.206 1347 29 
(SEM)* (0.077) (0.20) (0.010) (0.0068) (0.018) (209) (2) 
805 2.917 2.12 0.104 -0.0745 -0.158 2600 40 
810 2.555 2.89 0.155 -0.0635 -0.184 2241 40 
Mean 2.736 2.51 0.130 -0.0690* -0.171 2421** 40** 
(SEM) (0.181) (0.38) (0.026) (0.0055) (0.013) (180) (0) 
®SEM 
* P < 
= standard 
0.03. 
error of the mean. 
Table 10. Bile results for hepatic excretion of ICG in normal and 
shunted animals in Group 1 
Animal 
# 
QLB 
(ml 
min-1) 
PT 
(min) 
FC 
(mg L-1) 
AUCLB 
(mg min 
L-I)XL06) 
AUCLBM 
(mg min) 
AUCLBU 
(mg min 
L-1) 
502 0.185 41 1155 1.07 1045 21915 
504 0.167 40 748 1.30 1092 27379 
518 0.134 33 1680 1.47 941 120242 
520 0.111 35 1656 2.58 1443 118651 
523 0.148 54 893 1.64 1303 58993 
525 0.062 64 1941 3.52 1300 17815 
527 0.241 43 774 0.77 923 95201 
601 0.212 32 1003 0.49 519 32603 
603 0.202 32 980 0.90 903 57903 
Mean 0.162 42 1203 1.53 1052 61189 
(SEM)a (0.018) (4) (147) (0.32) (92) (13615) 
805 0.051 33 2274 2.81 730 350674 
810 0.113 45 1490 1.62 956 200472 
Mean 0.082* 39 1882 2.22 843 275573* 
(SEM) (0.031) (6) (392) (0.59) (80) (75101) 
S^EM = standard error of the mean, 
p < 0.05. 
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AUCLBMU %BU L^ED TLBCO TF 
(mg min) (min~l) (mln'L) • (CLBO) (min) %R (min) 
26.8 0.2287 -0.0248 8.549 345 95.4 142 
26.8 0.1445 -0.0073 6.746 924 80.0 176 
80.8 0.1055 -0.0311 9.440 304 94.5 153 
72.2 0.1131 -0.0117 7.880 674 83.4 191 
43.9 0.0901 -0.0099 7.245 732 76.2 190 
5.6 0.1871 -0.0168 8.930 532 75.7 192 
123.0 0.1039 -0.0208 7.857 378 75.7 139 
31.0 0.1832 -0.0892 13.457 151 66.1 112 
63.7 0.1856 -0.0253 8.320 329 83.3 167 
52.6 0.1491 -0.0263 8.718 485 81.1 162 
(12.0) (0.0163) (0.0083) (0.653) (83) (3.1) (9) 
97.2 0.0439 -0.0121 8.023 663 54.5 162 
126.1 0.1848 -0.0178 8.072 453 75.9 162 
111.7 0.1144 -0.0150 8.048 558 65.2 162 
(14.5) (0.0704) (0.0029) (0.025) (105) (10.7) (-) 
Table 11. Blood results for hepatic uptake of ICG in normal and shunted animals in Group 2 
Animal 
# In (Cgg) 
BV 
(L) 
BV/BW 
(L kg-1) 
K 
(min"!) 
CI 
(L . 
min 1) 
AUCb 
(mg min 
L-1) 
^BCO 
(min) 
ER 
(-) 
EHBF 
(ml 
min" ) 
EHBF/BW 
(ml . 
min" 
kg"l) 
817 2.853 2.39 0.101 -0.0554 -0.132 4243 50 8.4 28 1.2 
819 2.586 2.84 0.128 -0.0944 -0.268 983 25 34.4 13 0.6 
822 2.610 3.21 0.147 -0.1228 -0.394 606 20 14.9 53 2.4 
Mean 2.683 2.81 0.125 -0.0909 -0.265 1944 32 19.2 31 1.4 
(SEM)a (0.085) (0.24) (0.013) (0.0195) (0.076) (1155) (9.3) (7.8) (12) (0.5) 
831 2.580 2.86 0.143 -0.1328 -0.380 527 20 17.6 41 2.1 
907 2.718 2.68 0.138 -0.1123 -0.301 890 25 51.8 12 0.6 
Mean 2.649 2.77 0.141 -0.1226 -0.341 709 23 34.7 27 1.4 
(SEM) (0.069) (0.09) (0.002) (0.0103) (0.040) (182) (2.5) (17.1) (15) (0.8) 
S^EM = standard error of the mean. 
Table 12. Bile results for hepatic excretion of ICG in normal and 
shunted animals in Group 2 
Animal 
# 
QLB 
(ml 
min'l) 
PT 
(min) 
• Pc 
(mg L-1) 
AUClb 
(mg min 
1-1x10°) 
AUCLBM 
(mg min) 
AUCLBU 
(mg min 
L-1) 
817 0.041 56 2325 6.29 1253 304726 
819 0.271 44 910 1.29 1518 32031 
822 0.177 35 1061 1.59 1324 32325 
Mean 0.163 45 1432 3.06 1365 123027 
(SEM)® (0.067) (6) (449) (1.62) (79) (90849) 
831 0.105 64 1244 2.54 1280 15764 
907 —- — —  — —  
S^EM = standard error of the mean. 
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AUCLBMU L^BU %BD L^BCO Tp 
(mg min) (min'l) (min"!) (CiBo) (min) %R (min) 
55.6 0.0640 -0.0070 8.176 1166 51.8 206 
46.2 0.1443 -0.0047 6.251 1336 92.5 174 
32.5 0.1682 -0.0097 7.098 730 82.2 191 
44.8 0.1255 -0.0071 7.125 1077 75.5 190 
(6.7) (0.0315) (0.0014) (0.557) (180) (12.2) (9) 
9.8 0.1895 -0.0109 7.742 709 59.4 162 
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APPENDIX F: BASIC SOURCE LISTINGS OF DATA ANALYSIS 
PROGRAMS FOR PDP-ll/23/RTllOS COMPUTER 
120 
05 REM PROGRAM <KTEST.BAS> FOR EVALUATION OF BLOOD DATA 
10 DIM Y(IOO) 
20 PRINT "ENTER EXPERIMENT DATE (MOD) < Q=QUIT >"; \ INPUT A$ 
30 IF A$="Q" THEN 590 
40 PRINT \ A$="DY:BLD"+A$ 
50 IF A$="DY:BLD" THEN 20 
60 OPEN A$ FOR INPUT AS FILE #1 
70 B$=SEG$(A$,7,7) \ C$=SEG$(A$,8,9) 
80 FOR J=1 TO 100 \ IF END #1 THEN 130 \ LINPUT #1,E$ 
90 X=VAL(TRM$(SEG$(E$,1,4))) \ Y=VAL(TRM$(SEG$(E$,4,LEN(E$)))) 
100 IF Y<1 THEN Y=1 
110 Y(X)=LOG(Y) 
120 NEXT J 
130 CLOSE #1 \ F=J-1 
140 A=0 \ B=0 \ C=0 \ D=0 \ E=0 \ N=0 
150 PRINT "ENTER RANGE TO EVALUATE :"; \ INPUT P,Q 
160 FOR J=P TO Q 
170 A=A+J \ B=B+J2 \ C=C+J*Y(J) \ D=D+Y(J)2 \ E=E+Y(J) \ N=N+1 
180 NEXT J 
190 L=C-A*E/N \ K=B-A2/N \ M=D-E2/N \ S=L/K \ I=(E-S*A)/N \ R=L/SQR(K*M) 
200 PRINT "SLOPE="; S ; ; ;"INTERCEPT=";I ; ; ;"CORR. COEFF. =";R 
210 OPEN "BDT"+B$+C$+".DAT" FOR OUTPUT AS FILE #3 
220 M0=0 
230 FOR J=0 TO F 
240 PRINT #3,J,Y(J),S*J+I 
250 IF S*J+I<=0 THEN 280 
260 MO=MO+EXP(I)*EXP(S*J)*J 
270 NEXT J 
280 CLOSE #3 
282 IF S*J+I<=0 THEN 296 
284 J=J+1 \ GO TO 282 
296 J0=INT(J/5)*5 
298 FOR Z=J0 TO J \ MO=MO-EXP(I)*EXP(S*J)*J \ NEXT Z 
300 OPEN "KVL"+B$+C$+".DAT" FOR OUTPUT AS FILE #2 
310 PRINT #2,"EXPERIMENT DATE: 
320 PRINT #2,B$+"/"+C$+"/83" \ PRINT #2 \ PRINT #2 
330 PRINT "ENTER DYE DOSE"; \ INPUT DO \ PRINT #2,"DYE DOSE=";DO 
340 PRINT \ PRINT #2 
350 PRINT "ENTER HEMATOCRIT"; \ INPUT HO \ PRINT #2,"HEMATOCRIT^ ";HO 
360 PRINT \ PRINT #2 
370 B0=D0/EXP(I)/(1-H0/100) 
380 PRINT "DETERMINANT RANGE OF TIME FOR REGRESSION =";P;"TO";Q; 
"MINUTES" 
390 PRINT #2,"DETERMINANT RANGE OF TIME FOR REGRESSION =";P;"TO";Q; 
"MINUTES" 
400 PRINT \ PRINT #2 
410 PRINT "INTERCEPT=";I,"CORR. COEFF.=";R 
420 PRINT #2,"INTERCEPT="; I,"CORR. COEFF.=";R 
430 PRINT \ PRINT #2 
440 PRINT "K-VALUE=";S,"BLOOD VOLUME=";BO;"LITERS" 
450 PRINT #2,"K-VALUE=";S,"BL00D VOLUME=";BO;"LITERS" 
460 PRINT \ PRINT #2 
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470 PRINT TAB(17)"CLEARANCE=";S*BO;"l/MIN" \ PRINT#2,TAB(17) 
"CLEARANCE=";S*BO;"L/MIN" 
480 PRINT \ PRINT #2 
490 PRINT "K-VALUE/BODY WEIGHT=";S/DO;" /KG" \ PRINT 
500 PRINT "BLOOD VOLUME/BODY WEIGHT=";BO/DO;"L/KG" \ PRINT 
510 PRINT #2,"K-VALUE/BODY WEIGHT=";S/DO;"/KG","BLOOD VOLUME/BODY 
WEIGHT=";BO/DO;"L/KG" 
520 PRINT #2 
530 PRINT "AREA UNDER BLOOD CONCENTRATION CURVE=";M0;"MG-MIN/L" \ PRINT 
540 PRINT #2,"AREA UNDER BLOOD CONCENTRATION CURVE=";M0;"MG-MIN/L" 
545 PRINT#2 
550 PRINT "TIME OF ZERO BLOOD CONCENTRATION:";JO ;"MINUTES (NEAREST 5TH)" 
560 PRINT #2,"TIME OF ZERO BLOOD CONCENTRATION:";JO ;"MINUTES (NEAREST 
5TH)" 
570 PRINT \ PRINT #2 \ PRINT \ PRINT #2 
580 CLOSE #2 \ GO TO 10 
590 END 
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05 REM PROGRAM <BILTES.BAS> FOR EVALUATION OF BILE DATA 
10 DIM V(100),C(100),P(100),T(100),L(100),K(100) 
20 X=0 \ 2=0 
30 PRINT "ENTER EXPERIMENT DATE (MDD) < Q=QUIT> \ INPUT A$ \ PRINT 
35 PRINT 
40 IF A$="Q" THEN 880 
50 OPEN "DY:BIL"+A$+".DAT" FOR INPUT AS FILE #2 \ M1=0 \ M0=9999 
60 FOR J=1 TO 100 \ IF END #2 THEN 150 
70 LINPUT #2,C$ 
80 T=VAL(TRM$(SEG$(C$,1,5))) \ C=VAL(TRM$(SEG$(C$,6,LEN(C$)))) 
90 IF C<=0 THEN 140 
100 T(J)=T \ C(J)=C 
110 IF C(J)>M1 THEN M1=C(J) \ F=J 
120 IF J<M0 THEN M0=J 
130 IF T(J)=100 THEN U0=J 
140 NEXT J 
150 CLOSE #2 
160 IF C(F+1)=M1 THEN F=F+.5 
170 Q=J-1 
180 OPEN "DY:DPS"+A$+".DAT" FOR INPUT AS FILE #1 
190 FOR J=1 TO Q 
200 LINPUT #1,B$ 
210 IF VAL(TRM$(SEG$(B$,1,4)))=0 THEN 200 
220 IF J<MO THEN 260 
230 V(J)=VAL(TRM$(SEG$(B$,6,LEN(B$))))/lOOO 
240 X=X+V(J)'nOOO 
250 P(J)=V(J)*C(J) 
260 NEXT J \ CLOSE #1 
270 V=X/(Q*5) \ PRINT "FINAL TIME =";Q*5,"MEAN FLOW =";V \ PRINT 
275 IF A$="NOR" THEN 320 \ IF A$="SHN" THEN 320 
280 R=1.6/V \ PRINT "BILE CANNULA DELAY TIME =";R;"MINUTES" \ PRINT 
290 FOR J=MO TO Q \ IF T(J)-R<0 THEN M0=M0+1 
300 T(J)=T(J)-R 
310 NEXT J 
320 OPEN "DMS"+A$+".DAT" FOR OUTPUT AS FILE #3 
330 OPEN "PAC"+A$+".DAT" FOR OUTPUT AS FILE #4 
340 PRINT #3,Z,Z \ PRINT #4,Z,Z 
350 Y=0 \ PRINT "ENTER DYE DOSE:"; \ INPUT D \ PRINT \ PRINT 
360 PRINT "ENTER CUT-OFF TIME FOR UPSLOPE"; \ INPUT TO \ PRINT 
370 FOR J=MO TO Q 
380 PRINT #3,T(J),P(J) 
390 Y=Y+P(J)/D*100 \ PRINT #4,T(J),Y 
400 L(J)=L0G(C(J)) 
410 NEXT J \ CLOSE #3 \ CLOSE #4 
415 FOR J=MO TO Q \ IF INT(T(J))>T0 THEN 417 \ NEXT J 
417 H0=J-1 
420 PRINT "PERFORMING REGRESSION FOR UP-SLOPE RANGE";INT(T(MO));"TO"; 
INT(T(HO));"MINUTES" \ PRINT 
430 A0=0 \ B0=0 \ C0=0 \ D0=0 \ E0=0 \ N=0 
440 FOR J=MO TO HO 
450 AO=AO+T(J) \ BO=BO+T(J)2 \ CO=CO+T(J)*L(J) \ D0=D0+L(J)2 \ EO=EO+L(J) 
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455 N=N+1 
460 NEXT J 
470 L=C0-A0*E0/N \ K=B0-A02/N \ M=DO-E02/N 
480 S1=L/K \ I1=(E0-S1*A0)/N \ R1=L/SQR(K*M) 
490 PRINT "UP-SLOPE="; S1; ; ;"INTERCEPT="; 11; ; ;"CORR. COEFF. =";R1 \ PRINT 
500 A=0 \ B=0 \ Z0=0 \ Z1=0 
510 FOR J=MO TO Q 
520 A=A+C(J)*T(J) \ B=B+P(J)'VT(J) 
530 IF J>HO THEN 545 
540 ZO=ZO+EXP(L(J))*T(J) 
543 Z1=Z1+P(J)*T(J) 
545 NEXT J 
550 GO=(T(HO)+T(HO+l))/5 \ G1=T0-INT(T(H0)) 
553 G2=(L(H0)+L(H0+i))/5 
555 FOR J=1 TO G1 \ ZO=ZO+EXP(G2)*(T(HO)+GO) \ NEXT J 
560 U1=INT(T(U0)) 
570 PRINT "PERFORMING REGRESSION FOR DOWN-SLOPE RANGE";U1;"T0";INT(T(Q)); 
"MINUTES" 
580 PRINT \ A0=0 \ B0=0 \ C0=0 \ D0=0 \ E0=0 \ N=0 
590 FOR J=UO TO Q 
600 AO=AO+T(J) \ B0=B0+T(J)2 \ C0=C0+T(J)*L(J) \ D0=D0+L(J)2 \ EO=EO+L(J) 
605 N=N+l 
610 NEXT J 
620 L=CO-AO*EO/N \ K=B0-A02/N \ M=D0-E02/N 
630 S2=L/K \ I2=(E0-S2*A0)/N \ R2=L/SQR(K*M) 
640 PRINT "DOWN-SLOPE=";S2;;;"INTERCEPT=";I2;;;"CORR. COEFF. =";R2 \ PRINT 
650 OPEN "BLG"+A$+".DAT" FOR OUTPUT AS FILE #6 
660 FOR J=MO TO Q \ Wl=Sl*T(J)+Il \ W2=S2*T(J)+I2 
670 IF J>F THEN Wl=Sl*T(F)+Il 
680 PRINT #6,T(J),L(J),Wl,W2 
690 NEXT J 
700 CLOSE #6 
710 OPEN "BIN"+A$+".DAT" FOR OUTPUT AS FILE #5 
720 PRINT #5,"EXPERIMENT DATE : "+SEG$(A$,l,l)+"/"+SEG$(A$,2,3)+"/83" 
725 PRINT #5 
730 PRINT #5,"FINAL EXPERIMENTAL TIME : ";INT(T(Q));"MINUTES" \ PRINT #5 
740 PRINT #5,"MEAN BILE FLOW : ";V;" ML/MINUTE" \ PRINT #5 
750 PRINT #5,"BILE CANNULA DELAY TIME : ";R;"MINUTES" \ PRINT #5 
760 PRINT #5,"PEAK TIME : ";INT(T(F));"MINUTES" \ PRINT #5 
770 PRINT #5,"PEAK CONCENTRATION : ";M1;"MG/L" \ PRINT #5 
780 PRINT #5,"AREA UNDER BILE CONCENTRATION CURVE : ";A;"MG-MIN/L" \ 
PRINT#5 
790 PRINT #5,"AREA UNDER BILE MASS CURVE : ";B;"MG-MIN" \ PRINT #5 \ 
PRINT#5 
795 PRINT #5,"AREA UNDER BILE MASS CURVE TO";INT(T(HO))+Gl;"MINUTES :";Zl; 
"MG-MIN" \ PRINT #5 
800 PRINT #5,"AREA UNDER UP-SLOPE CURVE TO";INT(T(HO))+Gl;"MINUTES :";Z0; 
"MG-MIN/L" \ PRINT #5 
810 PRINT #5,"UP-SLOPE INTERCEPT CORR. COEFF. FROM TO 
(MINUTES)" 
820 PRINT #5," " 
124 
830 PRINT #5,S1;TAB(11);I1;TAB(27);R1;TAB(41);INT(T(M0));TAB(49);T0 
835 PRINT#5 
840 PRINT #5,"DOWN-SLOPE INTERCEPT CORR. COEFF. FROM 
(MINUTES)" 
850 PRINT #5," 
860 PRINT #5,S2;TAB(18);I2;TAB(34);R2;TAB(48);U1;TAB(54);INT(T(Q)) 
870 PRINT #5 \ PRINT #5 \ PRINT #5 \ PRINT #5,CHR$(12) \ CLOSE //5 \ 
GO TO 10 
880 END 
